Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 25, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2023 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 1-13445 | ||
Entity Registrant Name | Sonida Senior Living, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 75-2678809 | ||
Entity Address, Address Line One | 14755 Preston Road | ||
Entity Address, Address Line Two | Suite 810 | ||
Entity Address, City or Town | Dallas | ||
Entity Address, State or Province | TX | ||
Entity Address, Postal Zip Code | 75254 | ||
City Area Code | 972 | ||
Local Phone Number | 770-5600 | ||
Title of 12(b) Security | Common Stock, $.01 par value per share | ||
Trading Symbol | SNDA | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Financial Statement Error Correction | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 30.1 | ||
Entity Common Stock, Shares Outstanding (in shares) | 13,204,164 | ||
Documents Incorporated by Reference | Portions of the Registrant’s definitive proxy statement pertaining to its 2024 Annual Meeting of Stockholders and filed or to be filed not later than 120 days after the end of the fiscal year pursuant to Regulation 14A are incorporated herein by reference into Part III of this report. | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0001043000 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2023 | |
Audit Information [Abstract] | |
Auditor Firm ID | 49 |
Auditor Name | RSM US LLP |
Auditor Location | Dallas, Texas |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 4,082 | $ 16,913 |
Restricted cash | 13,668 | 13,829 |
Accounts receivable, net | 8,017 | 6,114 |
Federal and state income taxes receivable | 0 | 2 |
Prepaid expenses and other assets | 4,475 | 4,097 |
Derivative assets, current | 2,103 | 2,611 |
Total current assets | 32,345 | 43,566 |
Property and equipment, net | 588,179 | 615,754 |
Derivative assets, non-current | 0 | 111 |
Other assets, net | 936 | 1,837 |
Total assets | 621,460 | 661,268 |
Current liabilities: | ||
Accounts payable | 11,375 | 7,272 |
Accrued expenses | 42,388 | 36,944 |
Current portion of notes payable, net of deferred loan costs | 42,323 | 46,029 |
Current portion of deferred income | 4,041 | 3,419 |
Federal and state income taxes payable | 215 | 0 |
Other current liabilities | 519 | 653 |
Total current liabilities | 100,861 | 94,317 |
Other long-term liabilities | 49 | 113 |
Notes payable, net of deferred loan costs and current portion | 587,099 | 625,002 |
Total liabilities | 688,009 | 719,432 |
Commitments and contingencies (Note 11) | ||
Redeemable preferred stock: | ||
Series A convertible preferred stock, $0.01 par value; 41 shares authorized, 41 shares issued and outstanding as of December 31, 2023 and 2022 | 48,542 | 43,550 |
Shareholders’ deficit: | ||
Preferred stock, value | 0 | 0 |
Common stock, value | 82 | 67 |
Additional paid-in capital | 302,992 | 295,277 |
Retained deficit | (418,165) | (397,058) |
Total shareholders’ deficit | (115,091) | (101,714) |
Total liabilities, redeemable preferred stock and shareholders’ deficit | $ 621,460 | $ 661,268 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Convertible preferred stock, par value (in USD per share) | $ 0.01 | $ 0.01 |
Convertible preferred stock, shares authorized (in shares) | 41 | 41 |
Convertible preferred stock, shares issued (in shares) | 41 | 41 |
Convertible preferred stock, shares outstanding (in shares) | 41 | 41 |
Preferred stock, par value (in USD per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 15,000 | 15,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in USD per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 15,000 | 15,000 |
Common stock, shares issued (in shares) | 8,178 | 6,670 |
Common stock, shares outstanding (in shares) | 8,178 | 6,670 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenues: | ||
Revenues | $ 255,322 | $ 238,433 |
Expenses: | ||
Operating expense | 177,323 | 171,635 |
General and administrative expense | 32,198 | 30,286 |
Depreciation and amortization expense | 39,888 | 38,448 |
Long-lived asset impairment | 5,965 | 1,588 |
Managed community reimbursement expense | 21,099 | 27,371 |
Total expenses | 276,473 | 269,328 |
Other income (expense): | ||
Interest income | 608 | 235 |
Interest expense | (36,118) | (33,025) |
Gain (loss) on extinguishment of debt, net | 36,339 | (641) |
Other income (expense), net | (532) | 10,011 |
Loss before provision for income taxes | (20,854) | (54,315) |
Provision for income taxes | (253) | (86) |
Net loss | (21,107) | (54,401) |
Dividends on Series A convertible preferred stock | 0 | (2,269) |
Undeclared dividends on Series A convertible preferred stock | (4,992) | (2,300) |
Net loss attributable to common stockholders | $ (26,099) | $ (58,970) |
Per share data: | ||
Basic net loss per share (in USD per share) | $ (3.85) | $ (9.27) |
Diluted net loss per share (in USD per share) | $ (3.85) | $ (9.27) |
Weighted average shares outstanding — basic (in shares) | 6,786 | 6,359 |
Weighted average shares outstanding — diluted (in shares) | 6,786 | 6,359 |
Comprehensive loss | $ (21,107) | $ (54,401) |
Resident revenue | ||
Revenues: | ||
Revenues | 232,032 | 208,703 |
Management fees | ||
Revenues: | ||
Revenues | 2,191 | 2,359 |
Managed community reimbursement revenue | ||
Revenues: | ||
Revenues | $ 21,099 | $ 27,371 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Retained Deficit |
Beginning balance (in shares) at Dec. 31, 2021 | 6,634 | |||
Beginning balance at Dec. 31, 2021 | $ (46,810) | $ 66 | $ 295,781 | $ (342,657) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Series A convertible preferred stock dividends | (2,269) | (2,269) | ||
Undeclared dividends on Series A convertible preferred stock | (2,300) | (2,300) | ||
Stock-based plan activity (in shares) | 36 | |||
Stock-based plan activity | (261) | $ 1 | (262) | |
Non-cash stock-based compensation | 4,327 | 4,327 | ||
Net loss | (54,401) | (54,401) | ||
Ending balance (in shares) at Dec. 31, 2022 | 6,670 | |||
Ending balance at Dec. 31, 2022 | (101,714) | $ 67 | 295,277 | (397,058) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Issuance of common stock, net (in shares) | 1,068 | |||
Issuance of common stock, net | 10,000 | $ 11 | 9,989 | |
Undeclared dividends on Series A convertible preferred stock | (4,992) | (4,992) | ||
Stock-based plan activity (in shares) | 440 | |||
Stock-based plan activity | (27) | $ 4 | (31) | |
Non-cash stock-based compensation | 2,749 | 2,749 | ||
Net loss | (21,107) | (21,107) | ||
Ending balance (in shares) at Dec. 31, 2023 | 8,178 | |||
Ending balance at Dec. 31, 2023 | $ (115,091) | $ 82 | $ 302,992 | $ (418,165) |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating Activities | ||
Net loss | $ (21,107) | $ (54,401) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 39,888 | 38,448 |
Amortization of deferred loan costs | 1,552 | 1,281 |
(Gain) loss on derivative instruments, net | 2,981 | (19) |
Write-off of other assets | 0 | 535 |
Loss on sale of assets, net | 118 | 43 |
Long-lived asset impairment | 5,965 | 1,588 |
Casualty impairments | 0 | 1,100 |
(Gain) loss on extinguishment of debt | (36,339) | 641 |
Provision for bad debt | 1,151 | 1,159 |
Non-cash stock-based compensation expense | 2,749 | 4,327 |
Other non-cash items | (53) | (498) |
Changes in operating assets and liabilities: | ||
Accounts receivable, net | (3,249) | (2,354) |
Prepaid expenses and other assets | 2,918 | 8,303 |
Other assets, net | 276 | (141) |
Accounts payable and accrued expenses | 13,013 | (2,245) |
Federal and state income taxes receivable/payable | 217 | (601) |
Deferred income | 622 | 257 |
Customer deposits | (19) | (1) |
Net cash provided by (used in) operating activities | 10,683 | (2,578) |
Investing Activities | ||
Acquisition of new communities | 0 | (12,342) |
Capital expenditures | (17,938) | (24,562) |
Proceeds from sale of assets | 1,376 | 0 |
Net cash used in investing activities | (16,562) | (36,904) |
Financing Activities | ||
Proceeds from notes payable | 0 | 88,125 |
Repayments of notes payable | (13,802) | (102,351) |
Deferred loan costs paid | (825) | (2,361) |
Purchase of derivative assets | (2,362) | (2,703) |
Proceeds from issuance of common stock | 10,000 | 0 |
Shares withheld for taxes | 0 | (261) |
Dividends paid on Series A convertible preferred stock | 0 | (2,987) |
Other financing costs | (124) | (114) |
Net cash used in financing activities | (7,113) | (22,652) |
Decrease in cash and cash equivalents | (12,992) | (62,134) |
Cash and cash equivalents and restricted cash at beginning of year | 30,742 | 92,876 |
Cash and cash equivalents and restricted cash at end of year | 17,750 | 30,742 |
Cash paid during the year for: | ||
Interest | 28,251 | 29,626 |
Income taxes | 46 | 725 |
Non-cash investing and financing activities: | ||
Non-cash additions of property and equipment | 2,355 | 1,559 |
Undeclared dividends on Series A convertible preferred stock | 4,992 | 2,300 |
Insurance financed through insurance notes payable | $ 1,846 | $ 1,724 |
Organization and Business
Organization and Business | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Business | Organization and Business Sonida Senior Living, Inc., (formerly known as Capital Senior Living Corporation), a Delaware corporation (together with its subsidiaries, the “Company”), is one of the leading owner-operators of senior housing communities in the United States in terms of resident capacity. The Company owns, op erates, and manages senior housing communities throughout the United States. As of December 31, 2023, the Company operated 71 senior housing communities in 18 states with an aggregate capacity of approximately 8,000 residents, including 61 senior housi ng communities that the Company owned and 10 communities that the Company managed on behalf of third parties. The accompanying consolidated financial statements include the financial statements of Sonida Senior Living, Inc. and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. Shaker Heights Disposition In August 2023, the Company completed the sale of the Shaker Heights property for $1.0 million. The Company recognized a $0.2 million loss on the sale. The Shaker Heights property was unencumbered. Indiana Acquisition On February 1, 2022, the Company completed the acquisition of two senior living communities located in Indiana for a combined purchase price of $12.3 million. The communities consist of a total of 157 independent living units. The acquisition price was funded with cash on hand. The acquired assets did not meet the definition of a business and, as such, the transaction was accounted for as an asset acquisition pursuant to the guidance in subsection 805-50 of Accounting Standards Codification (“ASC”) 805, Business Combinations . |
Liquidity
Liquidity | 12 Months Ended |
Dec. 31, 2023 | |
Unusual or Infrequent Items, or Both [Abstract] | |
Liquidity | Liquidity During 2023, the Company's liquidity conditions, including operating losses and net working capital deficits, raised substantial doubt about the Company's ability to continue as a going concern. As a result of increases in occupancy occurring throughout 2023 and into the first quarter of 2024, rental rate increases in March 2024 and in connection with the 2024 private placement transaction and Protective Life loan purchase, the Company has substantially improved its liquidity position. See “Note 16–Subsequent Events” for details of the transactions which have increased cash on hand significantly. Based on these events, the Company concluded it has adequate cash to meet its obligations as they become due for the 12-month period following the date the December 31, 2023 financial statements are issued. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and related footnotes. Management bases its estimates and assumptions on historical experience, observance of industry trends and various other sources of information and factors, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates. Cash and Cash Equivalents and Restricted Cash The Company considers all highly liquid investments with original maturities of three months or less at the date of acquisition to be cash equivalents. The Company has deposits in banks that exceed Federal Deposit Insurance Corporation insurance limits. Management believes that credit risk related to these deposits is minimal. Restricted cash consists of reserve accounts for property insurance, real estate taxes, capital expenditures, derivative, and debt service required by certain loan agreements. In addition, restricted cash includes deposits required by certain counterparties as collateral pursuant to letters of credit which must remain so long as the letters of credit are outstanding, which are subject to renewal annually. The following table sets forth our cash and cash equivalents and restricted cash (in thousands): Years Ended December 31, 2023 2022 Cash and cash equivalents $ 4,082 $ 16,913 Restricted cash: Property tax and insurance reserves 7,237 6,184 Lender reserve 3,329 1,500 Capital expenditures reserves 2,060 2,034 Escrow deposit 1,000 — Deposits pursuant to outstanding letters of credit 42 4,111 Total restricted cash 13,668 13,829 Total cash, cash equivalents, and restricted cash $ 17,750 $ 30,742 Long-Lived Assets and Impairment Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful lives of the assets. At each balance sheet date, the Company reviews the carrying value of its property and equipment to determine if facts and circumstances suggest that they may be impaired or that the depreciation period may need to be changed. The Company considers internal factors, such as net operating losses, along with external factors relating to each asset, including contract changes, local market developments, and other publicly available information to determine whether impairment indicators exist. If an indicator of impairment is identified, recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company estimates fair value of the asset group and records an impairment loss when the carrying amount exceeds fair value. The Company recognized a non-cash impairment charges of $6.0 million to its "Property and equipment, net" during the year ended December 31, 2023, which related to one owned community. The Company recognized non-cash impairment charges of $1.6 million to its “ Property and equipment, net ” during the year ended December 31, 2022, which related to one owned community. See "Note 4–Impairment of Long-Lived Assets". In evaluating our long-lived assets for impairment, we undergo continuous evaluations of property level performance and real estate trends, and management makes several estimates and assumptions, including, but not limited to, the projected date of disposition, estimated sales price and future cash flows of each property during our estimated holding period. If our analysis or assumptions regarding the projected cash flows expected to result from the use and eventual disposition of our properties change, we incur additional costs and expenses during the holding period, or our expected hold periods change, we may incur future impairment losses. Upon the acquisition of new communities accounted for as an acquisition of assets, we recognize the assets acquired and the liabilities assumed as of the acquisition date, measured at their relative fair values once we have determined the fair value of each of these assets and liabilities. The acquisition date is the date on which we obtain control of the real estate property. The assets acquired and liabilities assumed consist of land, inclusive of associated rights, buildings, assumed debt, and identified intangible assets and liabilities. Fair Value Measurement The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2 Inputs – Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 Inputs – Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. The Company's other financial instruments consist primarily of cash and cash equivalents, receivables, accounts payable, accrued expenses, derivative financial instruments, and long-term debt. The carrying value of the Company’s receivables, trade payables, and accrued expenses approximates fair value due to their highly liquid nature, short-term maturity, or competitive rates assigned to these financial instruments. See “Note 13 – Fair Value.” The Company adjusts the carrying amount of certain non-financial assets to fair value on a non-recurring basis when they are impaired. Derivatives and Hedging The Company uses derivatives as part of our overall strategy to manage our exposure to market risks associated with the fluctuations in interest rates. We are also required to enter into interest rate derivative instruments in compliance with certain debt agreements. We regularly monitor the financial stability and credit standing of the counterparties to our derivative instruments. We do not enter into derivative financial instruments for trading or speculative purposes. We record all derivatives at fair value. As of December 31, 2023, our derivative instruments consisted of interest rate caps that were not designated as hedge instruments. Changes in fair value of undesignated hedge instruments are recorded in current period earnings as interest expense. See “Note 14–Derivatives and Hedging.” Stock-based Plans The Company applies the provisions of ASC 718, Compensation - Stock Compensation , in its accounting and reporting for stock-based compensation. ASC 718 requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. All unvested options outstanding under the Company's option plans have grant prices equal to the market price of the Company's stock on the dates of grant. Compensation cost for restricted stock and restricted stock units is determined based on the fair market value of the Company's stock at the date of grant. Stock-based compensation expense is generally recognized over the required service period, or over a shorter period when employee retirement eligibility is a factor. The Company recognizes forfeitures as they occur. Advertising Costs The Company expenses advertising costs as incurred. Advertising expense was approximately $1.5 million and $1.6 million for the years ended December 31, 2023 and 2022, respectively. Income Taxes Income taxes are computed using the asset and liability method and current income taxes are recorded based on amounts refundable or payable in the current year. The effective tax rates for fiscal year 2023 and 2022 differ from the statutory tax rates due to state income taxes, permanent tax differences, and changes in the deferred tax asset valuation allowance. Deferred income taxes are recorded based on the estimated future tax effects of loss carryforwards and temporary differe nces betw een financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the years in which the Company expects those carryforwards and temporary differences to be recovered or settled. Management regularly evaluates the future realization of deferred tax assets and provides a valuation allowance, if considered necessary, based on such evaluation. As part of the evaluation, management has evaluated taxable income in carryback years, future reversals of taxable temporary differences, feasible tax planning strategies, and future expectations of income. The Company evaluates uncertain tax positions through consideration of accounting and reporting guidance on criteria, measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition that is intended to provide better financial statement comparability among different companies. The Company is required to recognize a tax benefit in its financial statements for an uncertain tax position only if management’s assessment is that its position is “more likely than not” (i.e., a greater than 50 percent likelihood) to be upheld on audit based only on the technical merits of the tax position. The Company’s policy is to recognize interest related to unrecognized tax benefits as interest expense and penalties as income tax expense. Revenue Recognition Resident revenue consists of fees for basic housing and certain support services and fees associated with additional housing and expanded support requirements such as assisted living care, memory care, and ancillary services. Basic housing and certain support services revenue is recorded when services are rendered, and amounts billed are due from residents in the period in which the rental and other services are provided. Residency agreements are generally short term in nature with durations of one year or less and are typically terminable by either party, under certain circumstances, upon providing 30 days’ notice, unless state law provides otherwise, with resident fees billed monthly in advance. Revenue for certain ancillary services is recognized as services are provided, and includes fees for services such as medication management, daily living activities, beautician/barber, laundry, television, guest meals, pets, and parking which are generally billed monthly in arrears. Other operating revenue consists of state relief funds received from various states due to the financial distress impacts of COVID-19 ("State Relief Funds"). The Company's senior housing communities have residency agreements that generally require the resident to pay a community fee and other amounts prior to moving into the community, which are initially recorded by the Company as deferred revenue. The Company had contract liabilities for deferred fees paid by our residents prior to the month housing and support services were to be provided totaling approximately $4.0 million and $3.4 million, respectively, which is reported as deferred income within current liabilities of the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. Revenues from the Medicaid program accounted for approximately 10.4% and 10.0% of the Company’s revenue in fiscal years 2023 and 2022, respectively. During fiscal years 2023 and 2022, 24 and 24, respectively, of the Company’s communities were providers of services under the Medicaid program. Accordingly, these communities were entitled to reimbursement under the Medicaid program at established rates that were lower than private pay rates. Resident revenues for Medicaid residents were recorded at the reimbursement rates as the rates were set prospectively by the applicable state upon the filing of an annual cost report. None of the Company’s communities were providers of services under the Medicare program during fiscal years 2023 or 2022. Laws and regulations governing the Medicaid program are complex and subject to interpretation. The Company believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on its Consolidated Financial Statements. While no such regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties and exclusion from the Medicaid program. The Company has management agreements whereby it manages certain communities on behalf of third-party owners under contracts that provide for periodic management fee payments to the Company. The Company has determined that all community management activities are a single performance obligation, which is satisfied over time as the services are rendered. The Company’s estimate of the transaction price for management services also includes the amount of reimbursement due from the owners of the communities for services provided and related costs incurred. Such revenue is included in “managed community reimbursement revenue” on the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss). The related costs are included in “managed community reimbursement expense” on the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss). Revenue for the years ended December 31, 2023 and 2022 is comprised of the following components (in thousands): Years Ended December 31, 2023 2022 Housing and support services $ 226,148 $ 204,349 Community fees 1,775 1,898 Ancillary services 1,183 1,243 Other operating revenue (1) 2,926 1,213 Resident revenue 232,032 208,703 Management fees 2,191 2,359 Managed community reimbursement revenue 21,099 27,371 Total revenues $ 255,322 $ 238,433 ________ (1) Other operating revenue consists of State Relief Funds received from state departments due to financial distress impacts of COVID-19. For the years ended December 31, 2023 and 2022, the Company received approximately $2.9 million and $1.2 million in various State Relief Funds from state departments due to financial distress impacts of COVID-19. The Company received approximately $9.1 million for the year ended December 31, 2022 through grants from the Public Health and Social Services Emergency Fund’s (the “Provider Relief Fund”) Phase 4 General Distribution, which was expanded by the CARES Act to provide grants or other funding mechanisms to eligible healthcare providers for healthcare-related or lost revenues attributable to COVID-19. The Company recognizes income for government grants on a systematic and rational basis over the periods in which the Company recognizes the related expenses or loss of revenue for which the grants are intended to compensate when there is reasonable assurance that the Company will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. The Phase 4 Provider Relief Funds received from the Federal Government were recorded in “other income (expense), net” and the State Relief Funds were recorded as “resident revenue – other operating revenue” in the Company’s consolidated financial statements and notes thereto. Credit Risk and Allowance for Doubtful Accounts The Company’s resident receivables are generally due within 30 days after the date billed. Accounts receivable are reported net of an allowance for doubtful accounts of $5.3 million and $5.9 million as of December 31, 2023 and 2022, respectively, and represent the Company’s estimate of the amount that ultimately will be collected. The adequacy of the Company’s allowance for doubtful accounts is reviewed on an ongoing basis, using historical payment trends, write-off experience, analyses of receivable portfolios by payor source and aging of receivables, as well as a review of specific accounts, and adjustments are made to the allowance, as necessary. Credit losses on resident receivables have historically been within management’s estimates, and management believes that the allowance for doubtful accounts adequately provides for expected losses. Concentration of Credit Risk and Business Risk Substantially all of our revenues are derived from senior living communities we own and senior living communities that we manage. Senior living operations are particularly sensitive to adverse economic, social and competitive conditions and trends, including the effects of the COVID-19 pandemic, which has adversely affected, and may continue to adversely affect, our business, financial condition, and results of operations. We have a concentration of owned properties operating in Texas (16), Indiana (12), Ohio (10) and Wisconsin (8), which we estimate represented approximately 23%, 18%, 20%, and 10%, respectively, of our resident revenues for the year ended December 31, 2023. Self-Insurance Liability Accruals The Company offers full-time employees an option to participate in its health and dental plans. The Company is self-insured up to certain limits and is insured if claims in excess of these limits are incurred. The cost of employee health and dental benefits, net of employee contributions, is shared between the corporate office and the senior housing communities based on the respective number of plan participants. Contributions collected are used to pay the actual program costs, including estimated annual claims, third-party administrative fees, network provider fees, communication costs, and other related administrative costs incurred by the plans. Claims are paid as they are submitted to the Company’s third-party administrator. The Company records a liability for outstanding claims and claims that have been incurred but not yet reported. This liability is based on the historical claim reporting lag and payment trends of health insurance claims. Additionally, the Company may be liable for an Employee Shared Responsibility Payment (“ESRP”) pursuant to the Patient Protection and Affordable Care Act. The ESRP is applicable to employers that (i) had 50 or more full-time equivalent employees, (ii) did not offer minimum essential coverage (“MEC”) to at least 70% of full-time employees and their dependents, or (iii) did offer MEC to at least 70% of full-time employees and their dependents that did not meet the affordable or minimum value criteria and had one or more full-time employees certified as being allowed the premium tax credit. The Internal Revenue Service (“IRS”) determines the amount of the proposed ESRP from information returns completed by employers and from income tax returns completed by such employers' employees. Management believes that the recorded liabilities and reserves established for outstanding losses and expenses are adequate to cover the ultimate cost of losses and expenses incurred as of December 31, 2023. It is possible that actual claims and expenses may differ from established reserves. Any subsequent changes in estimates are recorded in the period in which they are determined. The Company uses a combination of insurance and self-insurance for workers’ compensation. Determining the reserve for workers’ compensation losses and costs that the Company has incurred as of the end of a reporting period involves significant judgments based on projected future events, including among other factors, potential settlements for pending claims, known incidents which may result in claims, estimates of incurred but not yet reported claims, changes in insurance premiums and estimated litigation costs. The Company regularly adjusts these estimates to reflect changes in the foregoing factors. However, since this reserve is based on estimates, it is possible the actual expenses incurred may differ from the amounts reserved. Any subsequent changes in estimates are recorded in the period in which they are determined. Net Income (Loss) Per Common Share The Company uses the two-class method to compute net income (loss) per common share because the Company has issued securities (Series A Preferred Stock) that entitle the holder to participate in dividends and earnings of the Company. Under this method, net income is reduced by the amount of any dividends earned during the period. The remaining earnings (undistributed earnings) are allocated based on the weighted-average shares outstanding of common stock and Series A Preferred Stock (on an if-converted basis) to the extent that each preferred security may share in earnings as if all of the earnings for the period had been distributed. The total earnings allocated to common stock is then divided by the number of outstanding shares to which the earnings are allocated to determine the earnings per share. The two-class method is not applicable during periods with a net loss, as the holders of the Series A Preferred Stock have no obligation to fund losses. Diluted net income (loss) per common share is computed under the two-class method by using the weighted-average number of shares of common stock outstanding, plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options, stock based compensation awards and warrants. In addition, the Company analyzes the potential dilutive effect of the outstanding Series A Preferred Stock under the “if-converted” method when calculating diluted earnings per share, in which it is assumed that the outstanding Series A Preferred Stock converts into common stock at the beginning of the period or when issued, if later. The Company reports the more dilutive of the approaches (two class or “if-converted”) as its diluted net income per share during the period. The following table sets forth the computation of basic and diluted net loss per common share (in thousands, except for per share amounts): Years Ended December 31, 2023 2022 Basic net loss per common share calculation: Net loss $ (21,107) $ (54,401) Less: Dividends on Series A Preferred Stock — (2,269) Less: Undeclared dividends on Series A Preferred Stock (4,992) (2,300) Net loss attributable to common stockholders $ (26,099) $ (58,970) Weighted average shares outstanding — basic 6,786 6,359 Basic net loss per share $ (3.85) $ (9.27) Diluted net loss per common share calculation: Net loss attributable to common stockholders $ (26,099) $ (58,970) Weighted average shares outstanding — diluted 6,786 6,359 Diluted net loss per share $ (3.85) $ (9.27) The following weighted-average shares of securities were not included in the computation of diluted net loss per common share as their effect would have been antidilutive: Years Ended December 31, (shares in thousands) 2023 2022 Series A Preferred Stock (if converted) 1,150 1,089 Warrants 1,031 1,031 Restricted stock awards 661 382 Restricted stock units 2 — Stock options 10 10 Total 2,854 2,512 Redeemable Preferred Stock The Company's Series A Preferred Stock is convertible outside of our control and in accordance with ASC 480-10-S99-3A and as such is classified as mezzanine equity. The Series A Preferred Stock was initially recorded at fair value upon issuance, net of issuance costs and discounts. The holders of our Series A Preferred Stock are Conversant Parkway (A) LP (“Conversant A”) and Conversant Parkway (B) LP (“Conversant B” and, together with Conversant A, “Conversant” or “Conversant Investors”), and are entitled to vote with the holders of common stock on all matters submitted to a vote of stockholders of the Company. As such, the Conversant Investors, in combination with their common stock ownership as of December 31, 2023 and 2022, have voting rights in excess of 50% of the Company’s total voting stock. It is deemed probable that the Series A Preferred Stock could be redeemed for cash by the Conversant Investors, and as such the Series A Preferred Stock is required to be remeasured and adjusted to its maximum redemption value at the end of each reporting period. However, to the extent that the maximum redemption value of the Series A Preferred Stock does not exceed the fair value of the shares at the date of issuance, the shares are not adjusted below the fair value at the date of issuance. As of December 31, 2023 and December 31, 2022, the Series A Preferred Stock is carried at the maximum redemption value. Dividends on redeemable preferred stock are recorded to retained earnings or additional paid-in capital if retained earnings is an accumulated deficit. Dividends are cumulative, and any declaration of dividends is at the discretion of the Company’s Board of Directors (the “Board”). If the Board does not declare a dividend in respect of any dividend payment date, the amount of such accrued and unpaid dividend is added to the liquidation preference and compounds quarterly thereafter. During the year ended December 31, 2023, the Board did not declare any dividends with respect to the Series A Preferred Stock, and accordingly, an aggregate of $5.0 million was added to the liquidation preference of the Series A Preferred Stock during such period, effectively increasing the carrying value of the redeemable preferred stock. See “Note 8–Securities Financing.” Segment Information The Company evaluates the performance of its senior living communities and allocates resources based on current operations and market assessments on a property-by-property basis. The Company does not have a concentration of operations geographically or by product or service as its management functions are integrated at the property level. The Company has determined that its operating units meet the criteria in ASC Topic 280, Segment Reporting , to be aggregated into one reporting segment. As such, the Company operates in one segment. Troubled Debt Restructurings The Company assesses its loan modifications with existing lenders to determine if it is a troubled debt restructuring. A loan that has been modified or renewed is considered to be a troubled debt restructuring when two conditions are met: (1) the borrower is experiencing financial difficulty and (2) concessions are made for the borrower’s benefit that would not otherwise be considered for a borrower or a transaction with similar credit risk characteristics. These concessions may include modifications of the terms of the debt such as deferral of payments, extension of maturity, reduction of principal balance, reduction of the stated interest rate other than normal market rate adjustments, or a combination of these concessions. The Company compares the total cash outflows of the restructured debt to the carrying amount of the debt prior to the restructure. If cash outflows of the restructured debt are less than the carrying amount, a gain is recognized and the carrying amount of the debt is adjusted. If cash outflows of the restructured debt are more than the carrying amount, no gain or loss is recognized and the carrying amount of the debt is not adjusted. The change in cash outflows resulting from the restructuring is accounted for on a prospective basis by calculating a new effective interest rate on the restructured debt and applying it to recognize lower interest expense over the remaining term. See “Note 7–Notes Payable.” Reclassifications Certain amounts previously reflected in the prior year consolidated financial statements have been reclassified to conform to our December 31, 2023 presentation. Off-Balance Sheet Arrangements The Company had no material off-balance sheet arrangements as of December 31, 2023 or 2022. Recently Adopted Accounting Pronouncements Allowance for Doubtful Account s In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments . Current GAAP requires an “incurred loss” methodology for recognizing credit losses that delays recognition until it is probable a loss has been incurred. ASU 2016-13 replaces the current incurred loss methodology for credit losses and removes the thresholds that companies apply to measure credit losses on financial statements measured at amortized cost, such as loans, receivables, and held-to-maturity debt securities with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to form credit loss estimates. The determination of the allowance for credit losses under the new standard would typically be based on evaluation of a number of factors, including, but not limited to, general economic conditions, payment status, historical collection patterns and loss experience, financial strength of the borrower, and nature, extent and value of the underlying collateral. For smaller reporting companies, ASU 2016-13 is effective for fiscal years and for interim periods within those fiscal years beginning after December 15, 2022. It requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. The Company adopted ASU 2016-13 on January 1, 2023. The effect of the adoption had an immaterial impact on our consolidated financial statements. Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on contracts, hedging relationships, and other transactions that reference the London InterBank Offered Rate. The new standard was effective upon issuance and elections can be made through December 31, 2022. The adoption of the optional expedient has not had and is not expected to have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted Segment Reporting In November of 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The ASU is effective on a retrospective basis for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on the disclosures within the Company's consolidated financial statements. Income Tax Disclosures In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The amendments require disclosure of specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold and further disaggregation of income taxes paid for individually significant jurisdictions. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact that this guidance will have on the disclosures within the Company's consolidated financial statements. |
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets | 12 Months Ended |
Dec. 31, 2023 | |
Asset Impairment Charges [Abstract] | |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful lives of the assets. At each balance sheet date, the Company reviews the carrying value of its property and equipment to determine if facts and circumstances indicate the carrying amount of an asset group may not be recoverable, or that the depreciation period may need to be changed. The Company considers internal factors such as net operating losses along with external factors relating to each asset, including contract changes, local market developments and other publicly available information to determine whether impairment indicators exist. If an indicator of impairment is identified, recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If the long-lived asset group’s carrying amount exceeds its estimated undiscounted future cash flows, the fair value of the long-lived asset group is then estimated by management and compared to its carrying amount. An impairment charge is recognized on these long-lived assets when carrying amount exceeds fair value. The Company recognized a non-cash impairment charge of $6.0 million to its “Property and equipment, net” during the year ended December 31, 2023, which related to one owned community. Due to recurring net operating losses, the Company concluded the assets related to this community had indicators of impairment and the carrying value was not recoverable. The fair value of the property and equipment, net of this community was determined using an income approach considering stabilized facility operating income, a discount rate of 8.5% and market capitalization rate of 7.5%. This impairment charge is primarily due to the COVID-19 pandemic and lower than expected operating performance at the community and reflects the amount by which the carrying amount of these assets exceeded their fair value. The Company recognized non-cash impairment charges of $1.6 million to its property and equipment, net during the year ended December 31, 2022, which related to one owned community. The impairment charge resulted from: a) the management's commitment to a plan to sell the community shortly after the balance sheet date, but before the issuance of this Annual Report on Form 10-K; and b) the agreed-upon selling price being below the community's carrying amount. In complying with the requirements under ASC 360, Property, Plant, and Equipment, management evaluated the significance of the asset in relation to the overall asset group, as well as the facts and circumstances surrounding the sale of this particular asset, and determined that no additional testing of the asset group under the held-and-used impairment approach was necessary at the balance sheet date. During the years ended December 31, 2023 and 2022, for long-lived assets where indicators of impairment were identified, tests of recoverability were performed, and the Company has concluded its property and equipment is recoverable and does not warrant adjustment to the carrying value or remaining useful lives, except for the long-lived asset noted above. |
Property and Equipment
Property and Equipment | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | Property and Equipment As of December 31, 2023 and 2022, property and equipment, net and leasehold improvements, which include assets under finance leases, consists of the following (in thousands): December 31, Asset Lives 2023 2022 Land NA $ 47,173 $ 47,476 Land improvements 5 to 20 years 20,487 20,053 Buildings and building improvements 10 to 40 years 845,873 842,854 Furniture and equipment 5 to 10 years 58,443 53,236 Automobiles 5 to 7 years 2,687 2,704 Leasehold improvements, and assets under finance leases (1) 2,766 1,899 Construction in progress NA 259 666 Total property and equipment $ 977,688 $ 968,888 Less accumulated depreciation and amortization (389,509) (353,134) Property and equipment, net $ 588,179 $ 615,754 _____________________________________ (1) Leasehold improvements are amortized over the shorter of the useful life of the asset or the remaining lease term. Assets under finance leases and leasehold improvements include $0.1 million and $0.2 million of finance lease right-of-use assets, net of accumulated amortization, as of December 31, 2023 and 2022, respectively. As of December 31, 2023 and 2022, property and equipment, net included $2.4 million and $1.6 million, respectively, of capital expenditures which had been incurred but not yet paid. During the years ended December 31, 2023 and December 31, 2022, the Company recognized non-cash impairment charges to “Property and equipment, net” of $6.0 million and $1.6 million, respectively. See “Note 4–Impairment of Long–Lived assets.” |
Accrued Expenses
Accrued Expenses | 12 Months Ended |
Dec. 31, 2023 | |
Payables and Accruals [Abstract] | |
Accrued Expenses | Accrued Expenses Accrued expenses consist of the following (in thousands): December 31, 2023 2022 Accrued payroll and employee benefits $ 15,639 $ 13,795 Accrued interest (1) 11,316 9,374 Accrued taxes 7,614 6,939 Accrued professional fees 5,022 3,179 Accrued other expenses 2,797 3,657 $ 42,388 $ 36,944 __________ (1) |
Notes Payable
Notes Payable | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Notes Payable | Notes Payable Notes payable consists of the following (in thousands): December 31, Weighted average Maturity Date 2023 2022 Fixed rate mortgage notes payable 4.6% 2024 to 2045 $ 492,998 $ 503,312 Fannie Mae - two mortgage notes payable (1) — 31,991 Variable rate mortgage notes payable (2) 5.9% 2026 to 2029 137,320 137,652 Notes payable - insurance 6.4% 2024 1,846 1,724 Notes payable - other 8.5% 2024 1,619 1,619 Notes payable $ 633,783 $ 676,298 Deferred loan costs, net 4,361 5,267 Total notes payable, net of deferred loan costs $ 629,422 $ 671,031 Current portion of notes payable (3) 42,323 46,029 Long-term notes payable, net $ 587,099 $ 625,002 The following schedule summarizes our notes payable as of December 31, 2023 (in thousands): Principal payments due in (4) : 2024 (3) $ 43,994 2025 34,208 2026 347,847 2027 3,597 2028 3,719 Thereafter 200,418 Total notes payable, excluding deferred loan costs $ 633,783 __________ (1) See “Transactions Involving Certain Fannie Mae Loans” disclosure below. (2) The weighted average interest rate for variable debt is the strike rate under the applicable interest rate cap agreements. See Note 14 for interest rate cap agreements on variable rate mortgage notes payable. (3) December 31 2023 includes $34.2 million aggregate outstanding principal due under the loans with Protective Life Insurance Company. See “Protective Life Insurance Company Non-recourse Mortgages” disclosure below. (4) Includes maturities of the subsequent refinancing that occurred with Ally Bank in February 2024. As of December 31, 2023, our fixed rate mortgage notes bear interest rates ranging from 3.6% to 6.3%. Our variable rate mortgage notes are based on the Secured Overnight Financing Rate (“SOFR”) plus an applicable margin. As of December 31, 2023, the one-month SOFR was 5.4%, and the applicable margins were either 2.14% or 3.50%. As of December 31, 2023, we had property and equipment with a net carrying value of $578.4 million that is secured by outstanding notes payable. Fannie Mae Loan Modification On June 29, 2023, the Company entered into the Fannie Forbearance with Federal National Mortgage Association (“Fannie Mae”) for all 37 of its encumbered communities, effective as of June 1, 2023 (“Fannie Forbearance Effective Date”). Under the Fannie Forbearance, Fannie Mae agreed to forbear on its remedies otherwise available under the community mortgages and Master Credit Facility (“MCF”) in connection with reduced debt service payments made by the Company during the forbearance period. In connection with the Fannie Forbearance, the Company made a $5.0 million principal payment in July 2023. The Fannie Forbearance was the first of a two-step process to modify all existing mortgage loan agreements with Fannie Mae by October 2023 under proposed loan modification agreements, as defined in the Fannie Forbearance (“Loan Modification Agreement”). T erms outlined in an agreed upon term sheet accompanying the Fannie Forbearance were included in the Loan Modification Agreements as the final step to modify the various 37 Fannie Mae community mortgages and MCF prior to the expiration of the Fannie Forbearance, which was subsequently extended to October 6, 2023. The Company entered into Loan Modification Agreements with Fannie Mae on October 2, 2023. The material terms of the Loan Modification Agreements are as follows: • Maturities on 18 community mortgages, ranging from July 2024 to December 2026, have been extended to December 2026. The remaining 19 communities under the MCF have existing maturities in January 2029. • The Company is not required to make scheduled principal payments due under the 18 community mortgages and 19 communities under the MCF through the revised maturity date of December 2026 or 36 months from the Fannie Forbearance Effective Date, respectively. • The monthly interest rate will be reduced by a 1.5% weighted average on all 37 communities for 12 months from the Fannie Forbearance Effective Date and deferred until it is contractually waived in June 2024 so long as there is no event of default (the “Fannie Interest Abatement Period”). • The Company is required to make a second principal payment of $5.0 million with respect to the Fannie Mae debt which is due on June 1, 2024, the one-year anniversary of the Fannie Forbearance Effective Date. • The Company provided a full corporate guaranty in the amount of $5.0 million related to the second principal payment of $5.0 million (the “Second Payment Guaranty”). This guaranty will fully expire upon payment of the second $5.0 million principal payment. • In addition to the Second Payment Guaranty above, the Company also provided a $10.0 million guaranty (the “Supplemental Fannie Guaranty”). After the expiration of 24 months from the Fannie Forbearance Effective Date, Sonida may discharge the full amount of the Supplemental Fannie Guaranty by making a $5.0 million principal payment to Fannie Mae on its community mortgages and/or its MCF. • In the first twelve months following the effective date of the Loan Modification Agreements, the Company is required to escrow 50% of Net Cash Flow less Debt Service (as defined in the Fannie mortgages and MCF) on an aggregate basis over all 37 Fannie Mae communities. The excess cash flow will be deposited into a lender-controlled capital expenditure reserve on a monthly basis to support the re-investment into certain communities, as mutually determined by the Company and Fannie Mae. The Company will be able to draw down such amounts on qualifying projects as the capital expenditures are incurred. As of December 31, 2023, the Company has funded $0.2 million into such escrow account. As of December 31, 2023, the Company had drawn down $10 million of the Equity Commitment as more fully described in “Note 8 –Securities Financing.” As of December 31, 2023, $3.5 million remains in the Equity Commitment. The Company has determined that the Fannie loan modification is a troubled debt restructuring where the total cash outflows exceed the current carrying value of the debt. The Company incurred restructuring costs of $0.7 million in the year ended December 31, 2023. These costs are included in deferred loan costs as of December 31, 2023 and will be amortized over the new lives of the Fannie Mae loans. In addition, the Company paid $3.1 million in transaction costs related to the loan modifications that were expensed as general and administrative expenses in the year ended December 31, 2023. Transactions Involving Certain Fannie Mae Loans The Coronavirus Aid, Relief and Economic Security Act of 2020 (“CARES Act”), among other things, permitted borrowers with mortgages from Government Sponsored Enterprises who experienced a financial hardship related to the COVID-19 pandemic to obtain forbearance of their loans for up to 90 days. During 2020, the Company entered into several loan forbearance agreements with Fannie Mae. In July 2020, the Company elected not to pay $3.8 million on the loans for 18 properties as of that date as it initiated a process intended to transfer the operations and ownership of such properties to Fannie Mae. Therefore, the Company was in default on such loans, which were non-recourse loans. As a result of the default, Fannie Mae filed a motion with the United States District Court (the “District Court”) requesting that a receiver be appointed over the 18 properties, which was approved by the District Court. The Company agreed to continue to manage the 18 communities, subject to earning a management fee, until management of the communities was transitioned to a successor operator or legal ownership of the properties was transferred to Fannie Mae or its designee. Management fees earned from the properties were recognized as revenue when earned. In conjunction with the receivership order, the Company was required to obtain approval from the receiver for all payments and received reimbursements from Fannie Mae for reasonable operating expenses incurred on behalf of any of the 18 communities under the receivership order. As a result of the events of default and receivership order, the Company discontinued recognizing revenues and expenses related to the 18 properties effective August 1, 2020, which was the date of default. In addition, the Company concluded that it was no longer entitled to receive any existing accounts receivable or revenue related to the properties, all amounts held in escrow by Fannie Mae were forfeited and the Company no longer had control of the properties in accordance with ASC 610-20. During the year ended December 31, 2021, Fannie Mae completed the transition of legal ownership of 16 of the Company's properties. As of December 31, 2022, two properties remained for which the legal ownership has not been transferred back to Fannie Mae. As of December 31, 2022, the Company included $31.8 million of outstanding debt in current portion of notes payable, net of deferred loan costs of $0.2 million. As of December 31, 2022, the accrued interest related to the remaining two properties was $4.1 million and was included in accrued expenses. As of December 31, 2022, the Company did not manage any properties on behalf of Fannie Mae. In January 2023, the Company received notice that the foreclosure sales conducted by Fannie Mae had successfully transitioned the remaining two properties to new owners which relieved the Company of the existing Fannie Mae debt. Accordingly, the Company recognized a $36.3 million gain on debt extinguishments for the year ended December 31, 2023. 2023 Ally Loan Amendment On June 29, 2023, and concurrent with the Fannie Forbearance, we executed the 2023 Ally Amendment to the Ally Term Loan Agreement and the Second Amended Ally Guaranty with Ally Bank with terms as follows: • With respect to the Second Amended Ally Guaranty, Ally will grant the Company, as Guarantor, a waiver (“Limited Payment Guaranty Waiver” or “Waiver”) of the Liquid Assets minimum requirement of $13.0 million for a 12-month period. On July 1, 2024, a new Liquid Assets Threshold of $7.0 million will be effective, with such threshold increasing $1.0 million per month through the earlier of the release of the Waiver period or December 31, 2024. • During the Waiver period, a new and temporary Liquid Assets minimum threshold (“Limited Payment Guaranty Waiver Minimum Threshold”) was established. The Limited Payment Guaranty Waiver Minimum Threshold is $6.0 million and is measured weekly. If breached, the “Excess Cash Flow Sweep” is triggered and all excess cash from the communities collateralizing the Ally Term Loan will be swept into an “Equity Cure Fund”, as defined in the Ally Term Loan Agreement. As provided for in the Ally Amendment, the Excess Cash Flow Sweep, if triggered, will cease upon the achievement of meeting or exceeding the Limited Payment Guaranty Waiver Minimum Threshold for four consecutive weeks. Consistent with the Ally Term Loan, all amounts held in escrow (i.e., Debt Service Escrow and IRC Reserve) will be included and combined with the Company’s unrestricted cash for purposes of measurement against the Limited Payment Guaranty Waiver Minimum Threshold. • During the Waiver period, Ally will collect the equivalent of the monthly Ally Term Loan principal payment (as provided for in the Ally Term Loan Agreement) of approximately $117,000 through an Ally controlled escrow (“Waiver Principal Reserve Account”). • Upon meeting the Ally Term Loan’s Liquid Assets Threshold of $13.0 million, the Company may elect to remove the Waiver, with initial terms in the Ally Term Loan applicable again, except as described further below. • In July 2023, we were required to fund $2.3 million to an interest rate cap reserve (“IRC Reserve”) held by Ally, which represented the quoted cost of a one-year interest rate cap on the full $88.1 million notional value of the Ally Term Loan at a 2.25% SOFR strike rate. On December 1, 2023, the Company entered into a new SOFR-based interest rate cap transaction for an aggregate notional amount of $88.1 million at a cost of $2.4 million. The interest rate cap agreement has a 12-month term and caps the floating interest rate portion of our indebtedness with Ally Bank at 2.25%. Until the terms of the Limited Payment Guaranty Waiver have expired or have been met and elected at the Company’s discretion, the IRC Reserve is required to be replenished to its replacement cost. • To the extent either the Second Payment Guaranty or Supplemental Fannie Guaranty have not been discharged, any uncured monetary event of default under the Fannie Forbearance will constitute a cross default under the Ally Amendment, resulting in the immediate trigger of a full excess cash flow sweep for the communities collateralizing the Ally Term Loan as well as additional performance and liquidity reporting requirements. • Subsequent to the Waiver period, all funds in the Waiver Principal Reserve Account as well as any funds swept into the Equity Cure Fund will be released to the Company. The foregoing description of the Fannie Forbearance, the 2023 Ally Amendment, Second Amended Ally Guaranty, and the Loan Modification Agreements and the transactions contemplated thereby do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the Fannie Forbearance, the Ally Amendment and Second Amended Ally Guaranty which are filed as Exhibits 10.21, 10.22 and 10.23, respectively, and the Loan Modification Agreements, which are filed as Exhibits 10.24 and 10.25 to this Annual Report on Form 10-K. See “ Item 15 . Exhibits .” 2022 Ally Loan Refinance In March 2022, the Company completed the refinancing of certain existing mortgage debt with Ally Bank (“Refinance Facility”) for ten of its communities. The Refinance Facility includes an initial term loan of $80.0 million. In addition, the Company provided a limited payment guaranty (“Limited Payment Guaranty”) of 33%, that reduces to 25% and then to 10%, of the then outstanding balance of the Refinance Facility based upon achieving certain financial covenants and then maintained over the life of the loan. As defined and required in the Limited Payment Guaranty, the Company was required to maintain certain covenants including maintaining a Tangible Net Worth of $150 million and Liquid Assets of at least $13 million which was inclusive of a $1.5 million debt service reserve provided by the Company at the closing of the Refinance Facility. The debt service reserve may be released upon terms described in the loan agreement and is included in restricted cash. In conjunction with the Refinance Facility, the Company incurred costs of $2.2 million in March 2022. These costs, net of amortization of $1.0 million, are included in deferred loan costs as of December 31, 2023. The financing transaction generated a loss on refinancing of notes payable of $0.6 million which is included in loss on extinguishment of debt for the year ended December 31, 2022. During December 2022, the Company amended the Refinance Facility with Ally Bank by adding two additional subsidiaries of the Company as borrowers and mortgaging their communities. The amendment increased the principal by $8.1 million to $88.1 million. The Refinance Facility also requires the financial performance of the twelve communities to meet certain financial covenants, including a minimum debt service coverage ratio and a minimum debt yield (as defined in the loan agreement) with a first measurement date as of June 30, 2022 and quarterly measurement dates thereafter. As of December 31, 2023, we were in compliance with the financial covenants. The Refinance Facility required the Company to purchase and maintain an interest rate cap facility during the term of the Refinance Facility. To comply with the lender’s requirement, the Company entered into an interest rate cap agreement for an aggregate notional amount of $88.1 million in November 2022 and entered into a new IRC agreement during December 2023. See “ Note 14–Derivatives and Hedging . ” Protective Life Insurance Company Non-recourse Mortgages At December 31, 2023, the Company had loan agreements with Protective Life Insurance Company (“Protective Life”), secured by seven of the Company's properties. During 2023, the Company elected not to make principal and interest payments related to certain non-recourse mortgage loan agreements with Protective Life covering four of the Company's properties. During August 2023, the Company paid all past due amounts on one of the properties to bring the mortgage current. As of December 31, 2023, the Company remained in default on three of the Company's properties with Protective Life with an aggregate principal amount of $55.8 million. On February 2, 2024, the Company completed the purchase of the total outstanding balance of $74.4 million from Protective Life that was secured by seven of the Company’s senior living communities for a purchase price of $40.2 million (such transaction, the “Protective Life Loan Purchase”). On February 2, 2024, in connection with the Protective Life loan purchase, the Company expanded its outstanding loan obligation with Ally Bank in the amount of $24.8 million that was secured by six of the Company's senior living communities. See “ Note 16–Subsequent Events .” Notes Payable - Insurance During the year ended December 31, 2023, the Company renewed certain insurance policies and entered into several finance agreements totaling approximately $3.3 million. During the year ended December 31, 2022, the Company renewed certain insurance policies and entered into several finance agreements totaling approximately $3.1 million. As of December 31, 2023, the Company had finance agreements outstanding totaling $1.8 million, with fixed interest rates ranging from 6.25% to 6.50%, and weighted average rate of 6.38%, with the principal being repaid over ten-month terms. Other Debt Related Transactions The Company had notes payable related to rent payments due to Healthpeak for the years ended December 31, 2023 and 2022. As of December 31, 2023, the Company had $1.6 million due to Healthpeak, which is included in notes payable. In November 2023, the Company modified its payment terms on the Healthpeak note payable to include four consecutive quarterly installments beginning in January 2024. Deferred Loan Costs As of December 31, 2023 and December 31, 2022, the Company had gross deferred loan costs of approximately $11.6 million and $11.3 million, respectively. Accumulated amortization was approximately $7.3 million and $6.0 million as of December 31, 2023 and December 31, 2022, respectively. Debt Covenant Compliance Except for the non-compliance with certain mortgage loan agreements on three communities with Protective Life, the Company was in compliance with all other aspects of its outstanding indebtedness as of December 31, 2023. |
Securities Financing
Securities Financing | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Securities Financing | Securities Financing Series A Preferred Stock The Company has an investment agreement with the Conversant Investors (“A&R Investment Agreement”) which closed on November 3, 2021 (“Closing Date”) under the terms of which the Company (i) issued to the Conversant Investors 41,250 shares of Series A Preferred Stock of the Company, par value $0.01 per share, at $1,000 per share (“Series A Preferred Stock”), 1,650,000 shares of common stock of the Company, par value $0.01 per share, at $25 per share, and 1,031,250 warrants to purchase common stock at $40 per share and (ii) offered a common stock rights offering to the Company’s existing stockholders (the “Rights Offering”), pursuant to which such common stock holders purchased an additional 1,133,941 shares of common stock at $30 per share. The Conversant Investors and Arbiter Partners QP, LP (“Arbiter”) backstopped the Rights Offering, pursuant to which they purchased an additional 1,160,806 and 114,911 shares of common stock, respectively, and received a backstop fee amounting to 174,675 shares of common stock and 17,292 shares of common stock, respectively. With respect to the distribution of assets upon liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, the Series A Preferred Stock will rank: (i) on a parity basis with each other class or series of capital stock of the Company now existing or hereafter authorized, classified or reclassified, the terms of which expressly provide that such class or series ranks on a parity basis with the Series A Preferred Stock as to dividends or rights; and (ii) junior to each other class or series of capital stock of the Company hereafter authorized, classified or reclassified, the terms of which expressly provide that class or series. In the event of a Change of Control (as defined in the A&R Investment Agreement), the Series A Preferred Stockholders hold a liquidation preference that is equal to $1,000 per share plus the sum of preferred dividends and other dividends paid as additional stock plus any accrued and unpaid dividends (the “Liquidation Preference”). The Series A Preferred Stock has an 11% annual dividend calculated on the original investment of $41.25 million accrued quarterly in arrears and compounded. Dividends are guaranteed and may be paid in cash or in additional Series A Preferred Stock shares at the discretion of the Company’s Board of Directors. Generally, the Series A Preferred Stockholders do not have special voting rights and have voting rights consistent with common stockholders as if they were one class. Series A Preferred Stockholders are entitled to a number of votes in respect of the shares of Series A Preferred Stock owned by them equal to the number of shares of common stock into which such shares of Series A Preferred Stock would be converted. Dividends are cumulative, and any declaration of dividends is at the discretion of the Company’s Board of Directors. If the Board does not declare a dividend in respect of any dividend payment date, the amount of such accrued and unpaid dividend is added to the liquidation preference and compounds quarterly thereafter. During the year ended December 31, 2022, the Company declared and paid $2.2 million cash dividends on the Series A Preferred Stock. During the quarter ended September 30, 2022, and the quarter ended December 31, 2022, the Board did not declare dividends, and accordingly, $2.3 million was added to the liquidation preference of the Series A Preferred Stock. During the year ended December 31, 2023, the Board did not declare dividends, and accordingly, $5.0 million was added to the liquidation preference of the series A Preferred Stock. The Series A Preferred Stockholders (“Holder”) have the right at any time to convert (an “Optional Conversion”) each share of Series A Preferred Stock into common stock as described in the Certificate of Designation, Preferences and Rights of Series A Convertible Preferred Stock. The right of Optional Conversion may be exercised as to all or any portion of such Holder’s Series A Preferred Stock from time to time, except that, in each case, no right of Optional Conversion may be exercised by a Holder in respect of fewer than 1,000 shares of Series A Preferred Stock (unless such conversion relates to all shares of Series A Preferred Stock held by such Holder). If an Optional Conversion Date occurs on or after the Record Date for a Dividend and on or before the immediately following Dividend Payment Date and Dividends have been declared for such Dividend Payment Date, then (x) on such Dividend Payment Date, such Dividend will be paid to the Holder of each share of Series A Preferred Stock as of the close of business on the applicable Record Date for such Dividend, notwithstanding the Holder’s exercise of an Optional Conversion, and (y) the amount of such Dividend, if a Preferred Dividend, will not be included in the Liquidation Preference referred to in clause (a) above. At any time on or after the third anniversary of the Closing Date, the Company may elect, upon the approval of a majority of the independent and disinterested directors of the Board of Directors, to convert all, but not less than all, of the outstanding shares of Series A Preferred Stock into shares of common stock by delivery to the Series A Preferred Stock holders of a notice of Mandatory Conversion (as defined in the A&R Investment Agreement), provided, that the Company shall not be entitled to deliver an irrevocable notice of Mandatory Conversion unless the volume-weighted average price (“VWAP”) per share of common stock exceeds 150% of the Conversion Price (as defined in the A&R Investment Agreement) for the 30 consecutive trading days immediately preceding the notice. The Company has the option to exercise its right to require the Conversant Investors to convert their Series A Preferred Stock, once VWAP has met the above requirements for this contingent call. In the case of a Mandatory Conversion, each share of Series A Preferred Stock then outstanding will be converted into (i) a number of shares of common stock equal to the quotient of (a) the Liquidation Preference of such share of Series A Preferred Stock as of the applicable Mandatory Conversion date, divided by (b) the Conversion Price as of the applicable Mandatory Conversion date and (ii) cash in lieu of fractional shares. If the Mandatory Conversion date occurs on or after the record date for a dividend and on or before the immediately following dividend payment date and dividends have been declared for such date, then such dividend will be paid to the Series A Preferred Stock holder of each share of Series A Preferred Stock as of the close of business on the applicable record date, notwithstanding the Company’s exercise of a Mandatory Conversion, and the amount of such dividend, if a Series A Preferred Stock dividend, will not be included in the Liquidation Preference. The Company may, at its option, irrevocably elect to redeem the Series A Preferred Stock, in whole or in part, at any time (i) on or after the forty-second month anniversary of the Closing Date (and before the seventh anniversary), at a cash redemption price per share of Series A Preferred Stock equal to the greater of (A) 100% of the Liquidation Preference as of such redemption date and (B) an amount equal to (a) the number of shares of common stock issuable upon conversion of such share of Series A Preferred Stock as of the redemption date, multiplied by (b) the VWAP of common stock for the 30 trading days immediately preceding the notice date and (c) on or after the seventh anniversary of the original issue date, at a redemption price per share of Series A Preferred Stock equal to 100% of the Liquidation Preference as of the redemption date. The Conversant Investors, in combination with their common stock ownership as of December 31, 2021, have voting rights in excess of 50% of the Company’s total voting stock. It is therefore deemed probable that the Series A Preferred Stock could be redeemed for cash by the Conversant Investors, and as such the Series A Preferred Stock is required to be adjusted to its maximum redemption value at the end of each reporting period. However, to the extent that the maximum redemption value of the Series A Preferred Stock does not exceed the fair value of the shares at the date of issuance, the shares are not adjusted below the fair value at the date of issuance. As of December 31, 2023 and 2022, the Series A Preferred Stock was carried at the maximum redemption value. The redemption amount at each balance sheet date should include amounts representing dividends not currently declared or paid but which will be payable under the redemption features. The Series A Preferred Stock does not have a maturity date and therefore is considered perpetual. The Series A Preferred Stock is redeemable outside of the Company’s control and is therefore classified as mezzanine equity in the Consolidated Balance Sheet of the Company as of December 31, 2023 and 2022. Changes in the Series A Preferred Stock are as follows: Series A Preferred Stock Shares Amount (In thousands) Balance as of December 31, 2021 41 $ 41,250 Undeclared dividends on Series A Preferred Stock — 2,300 Balance as of December 31, 2022 41 43,550 Undeclared dividends on Series A Preferred Stock — 4,992 Balance as of December 31, 2023 41 $ 48,542 Warrants On November 3, 2021, the Company issued 1,031,250 warrants to the Conversant Investors, each evidencing the right to purchase one share of common stock at a price per share of $40 and with an exercise expiration date of five years after the Closing Date. The value of the warrants, adjusted for the pro-rata share of issuance costs and other discounts was included in Additional Paid in Capital in the Consolidated Balance Sheet of the Company as of December 31, 2023 and 2022. Investor Rights For so long as the Conversant Investors beneficially own at least 33% of the Company’s outstanding common stock on an as-converted basis, Conversant Dallas Parkway (A) LP, a Delaware limited partnership (“Investor A”) shall be entitled to designate four members of the Company’s Board of Directors including the Chairperson. For so long as the Conversant Investors beneficially own less than 33% but at least 15% or more of the outstanding shares of common stock of the Company on an as-converted basis, Investor A will have the right to designate a number of directors, rounded to the nearest whole number, equal to the quotient of the total number of outstanding shares of common stock of the Company on an as-converted basis beneficially owned by the Conversant Investors divided by the total number of outstanding shares of common stock of the Company on an as-converted basis, multiplied by the total number of directors then on the Board including the Chairperson for so long as the Conversant Investors beneficially own at least 20% or more of the outstanding shares of common stock on an as-converted basis. For so long as the Conversant Investors beneficially own less than 15% but at least 5% or more of the outstanding shares of common stock of the Company on an as-converted basis, Investor A will have the right to designate one designee for inclusion in the Company’s slate of individuals nominated for election to the Board (which slate will include a number of nominees equal to the number of director positions to be filled). After 3.5 years the Conversant Investors can designate 5 board seats if their beneficial ownership exceeds 50%. For so long as Silk Partners, LLC with its affiliates (collectively, “Silk”) beneficially own at least 5% of the outstanding shares of common stock of the Company on an as-converted basis, Silk will have the right to designate two designees for inclusion in the Company’s slate of individuals nominated for election to the Board of Directors (which slate will include a number of nominees equal to the number of director positions to be filled). Conversant Equity Commitment In connection with the Fannie Forbearance and Ally Amendment signed on June 29, 2023, the Company entered into a $13.5 million equity commitment agreement (“Equity Commitment”) with Conversant Investors for a term of 18 months. The Equity Commitment had a commitment fee of $675,000, which was paid through the issuance of 67,500 shares of common stock of the Company. The commitment fee shares were issued to Conversant on June 29, 2023. Subject to certain conditions, the Company has the right, but not the obligation, to utilize Conversant’s equity commitment and may draw on the commitment in whole or in part. The Company made an equity draw in July 2023 of $6.0 million and issued 600,000 shares of common stock to Conversant. We used $5.0 million of the proceeds to make unscheduled principal payments on two of our Fannie Mae loan balances. On November 1, 2023, the Company made an equity draw of $4.0 million and issued 400,000 shares of common stock to the Conversant Investors. |
Stock-Based Compensation
Stock-Based Compensation | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation The Company’s uses equity awards as a long-term retention program that is intended to attract, retain and provide incentives for employees, officers, and directors and to more closely align stockholder and employee interests. The Company recognizes compensation expense for all our share-based stock awards based on their fair values. On June 15, 2023, the Company's stockholders approved an amendment to the 2019 Omnibus Stock and Incentive Plan, as amended (the “2019 Plan”), to add an additional 500,000 shares of common stock that the Company may issue under the 2019 Plan and removed the limitation of the maximum number of shares of common stock with respect to which awards may be granted to any one participant during any calendar year. T he Company has reserved shares of common stock for future issuance pursuant to awards under the 2019 Plan. Stock Options The Company’s stock options generally vest over one There were 9,816 options outstanding as of December 31, 2023 and 2022. The options outstanding as of December 31, 2023 and 2022 had no intrinsic value, a weighted-average remaining contractual life of 5.0 years, and a weighted-average exercise price of $111.90. As of December 31, 2023, there was no unrecognized compensation expense related to unvested stock option awards. The fair value of the stock options is amortized as compensation expense over the vesting periods of the options. The Company recorded no stock-based compensation expense related to stock options in the years ended December 31, 2023 and 2022. Restricted Stock Units Restricted stock units (“RSUs”) may be granted to members of the Company’s Board of Directors (“Directors”) as part of their compensation. Awards have a vesting period of one year; however, the Directors may defer the release of the RSU until their departure from the board. Compensation expense is recognized over the vesting period on a straight-line basis. The fair value of RSUs is the market close price of the Company’s common stock on the date of the grant. A summary of restricted stock units’ activity is presented in the table below: Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 12,816 $ 102.20 Granted 8,739 26.50 Vested (12,816) 102.20 Non-vested shares as of December 31, 2022 8,739 $ 26.50 Granted 3,000 8.80 Vested (8,739) 26.50 Non-vested shares as of December 31, 2023 3,000 $ 8.80 Restricted Stock Awards Restricted stock awards (“RSAs”) entitle the holder to receive shares of the Company’s common stock as the awards vest. RSAs are considered outstanding at the time of grant since the holders thereof are entitled to dividends, upon vesting, and voting rights. Grants of restricted stock awards are classified as time-based, performance-based, or market-based, depending on the vesting criteria of the award. Time-Based Restricted Stock Awards Time-based RSAs generally vest over three Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 112,319 $ 39.51 Granted 70,101 28.14 Forfeited/Cancelled (79,327) 34.99 Vested (21,965) 51.97 Non-vested shares as of December 31, 2022 81,128 $ 30.75 Granted 56,400 7.50 Forfeited/Cancelled (2,913) 26.50 Vested (26,044) 28.72 Non-vested shares as of December 31, 2023 108,571 $ 19.26 Performance-Based Restricted Stock Awards Vesting of performance-based stock awards (“PSAs”) is dependent upon attainment of various levels of performance that equal or exceed targeted levels and generally vest in their entirety one Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 — $ — Granted 87,674 28.47 Forfeited/Cancelled (35,055) 31.58 Non-vested shares as of December 31, 2022 52,619 $ 26.40 Granted 96,600 7.03 Non-vested shares as of December 31, 2023 149,219 $ 13.86 Market-Based Restricted Stock Awards Market-based restricted stock awards become eligible for vesting upon the achievement of specific market-based conditions based on the per share price of the Company’s common stock. The Company grants certain employees market-based restricted stock awards generally with either three or four tranches that vest if the Company’s stock price closes at or above an established threshold for each tranche for a specified number of consecutive trading days within five years of the date of the grant. Compensation expense related to market-based restricted stock awards is recognized over the requisite service period on a straight-line basis. The requisite service period is a measure of the expected time to reach the respective vesting threshold and was estimated by utilizing a Monte Carlo simulation, considering only those stock price-paths in which the threshold was exceeded. A summary of market-based restricted stock awards’ activity is presented in the table below: Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 188,411 $ 28.20 Granted 60,039 23.19 Converted to Time-Based (77,100) 27.02 Non-vested shares as of December 31, 2022 171,350 $ 26.97 Granted 293,600 8.12 Non-vested shares as of December 31, 2023 464,950 $ 15.07 The Company recognized $2.7 million and $4.3 million in stock-based compensation expense during fiscal years 2023 and 2022, respectively, that is primarily associated with employees whose corresponding salaries and wages are included in general and administrative expenses within the Company’s Consolidated Sta tements of Operations and Comprehensive Income (Loss). |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The provision for income taxes consists of the following (in thousands): Years Ended December 31, 2023 2022 Current: Federal $ — $ — State 253 86 Deferred: Federal — — Provision for income taxes $ 253 $ 86 The provision for income taxes differed from the amounts of income tax (benefit) provision determined by applying the U.S. federal statutory income tax rate to income before (benefit) provision for income taxes as a result of the following (in thousands): Years Ended December 31, 2023 2022 Tax (benefit) provision at federal statutory rates $ (4,374) $ (11,407) State income tax (benefit) provision, net of federal effects 520 (716) Change in deferred tax asset valuation allowance 1,566 11,253 Stock based compensation expense 335 457 Permanent impact of employee retention credit claims 2,302 — Other (96) 499 Provision for income taxes $ 253 $ 86 The effective tax rate for fiscal year 2023 differs from the statutory tax rate primarily due to state income taxes, changes in the deferred tax asset valuation allowance and other permanent tax differences. The Company is impacted by the Texas Margin Tax (“TMT”), which effectively imposes tax on modified gross revenues for communities within the State of Texas and accounts for the majority of the Company’s current state tax expense. The fiscal year 2023 other permanent tax differences include $0.3 million of Section 162(m) of the Internal Revenue Code of 1986, as amended compensation limitation. The valuation allowance recorded as of fiscal year 2023 was $100.8 million, which increased from the prior year by $1.6 million due to current year activity. The effective tax rate for fiscal year 2022 differs from the statutory tax rate primarily due to state income taxes, changes in the deferred tax asset valuation allowance and other permanent tax differences. The Company is impacted by the TMT, which effectively imposes tax on modified gross revenues for communities within the State of Texas and accounts for the majority of the Company’s current state tax expense. The fiscal year 2022 other permanent tax differences include $0.5 million Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”) compensation limitation and $0.3 million deferred payroll tax penalty. The valuation allowance recorded as of December 31, 2022 was $99.3 million, which had increased from the prior year by $11.3 million due to current year activity. A summary of the Company’s deferred tax assets and liabilities, are as follows (in thousands): December 31, 2023 2022 Deferred tax assets: Lease liabilities $ 377 $ 413 Net operating loss carryforward 92,251 84,899 Compensation costs 3,233 2,491 Depreciation and amortization 1,884 9 Other 3,119 11,526 Total deferred tax assets 100,864 99,338 Deferred tax asset valuation allowance (100,838) (99,273) Total deferred tax assets, net 26 65 Deferred tax liabilities: Operating lease right-of-use assets (26) (65) Total deferred tax liabilities (26) (65) Deferred taxes, net $ — $ — A valuation allowance has been recorded to reduce the Company’s net deferred tax assets to the amount that is more likely than not to be realized. A significant component of objective evidence evaluated was the cumulative losses before income taxes incurred by the Company over the past several fiscal years. Such objective evidence severely limits the ability to consider other subjective evidence such as the Company’s ability to generate sufficient taxable income in future periods to fully recover the deferred tax assets. However, in the event that the Company were to determine that it would be more likely than not that the Company would realize the benefit of deferred tax assets in the future in excess of their net recorded amounts, adjustments to deferred tax assets would increase net income in the period of such a determination. The CARES Act contains beneficial provisions to the Company, including the deferral of certain employer payroll taxes and the acceleration of the alternative minimum tax credit refunds. Additionally, on December 27, 2020, the Consolidated Appropriates Act was enacted providing that electing real property trades or business electing out of section 163(j)(7)(B) will apply a 30 year ADS life to residential real property, including property placed in service before January 1, 2018. This property had historically been assigned a 40 year ADS life under the Tax Cuts and Jobs Act of 2017 (“TJCA”). As of December 31, 2023, the Company has federal and state net operating loss (“NOL”) carryforwards of $389.5 million and $305.2 million and related deferred tax assets of $81.8 million and $13.6 million, respectively. The Company filed for an employee retention credit (“ERC”) with the Internal Revenue Service during the fourth quarter of 2023, which was before the announced moratorium on processing new claims. As the Company will need to file amended tax returns for the years the credit was claimed, a reduction to the federal NOL was recorded in 2023 of $11.3 million for the wages claimed. The federal and state NOL carryforwards in the income tax returns filed included unrecognized tax benefits. The deferred tax assets recognized for those NOLs are presented net of the unrecognized benefits. If not used, the federal NOL generated prior to fiscal year 2018 will expire during fiscal years 2033 to 2037 and non-conforming state NOLs will expire during fiscal years 2023 to 2042. Federal NOLs generated subsequent to fiscal 2017 currently have no expiration due to changes to tax laws enacted with the TCJA. Some state jurisdictions conform to the unlimited net operating loss carryforward provisions as modified by the TCJA. However, some jurisdictions do not conform to the above-mentioned provisions. In general, utilization of the net operating loss carryforwards are subject to a substantial annual limitation due to ownership changes that occur or that could occur in the future, as required by Section 382 of the Code. These ownership changes limit the amount of NOL carryforwards that can be utilized annually to offset taxable income and tax, respectively. In general, an “ownership change” as defined by Section 382 of the Code results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders or public groups. The Company had a change in ownership as defined by Section 382 of the Code on November 3, 2021. The Company has completed initial analysis of the annual Section 382 limitation and determined the annual utilization of its tax attributes is limited substantially, including consideration of net unrealized built-in gains on the Company’s assets resulting in an increase in the Section 382 limit over the five-year recognition period. The ownership activity subsequent to November 3, 2021 is under analysis for potential Section 382 triggering events. Tax attributes to which the annual Section 382 limitation would apply include net operating losses generated prior to the ownership change. There is no current or projected utilization of the NOL carryforwards in the near future. The Company maintains a valuation allowance in all jurisdictions where the NOL carryovers are present. A summary of the Company’s unrecognized tax benefits activity and related information for the years ended December 31, 2023 and 2022 is presented below (in thousands): Years Ended December 31, 2023 2022 Beginning balance, January 1 $ 2,796 $ 2,383 Gross increases – tax positions in prior period 397 413 Ending balance, December 31 $ 3,193 $ 2,796 As of December 31, 2023, the Company has unrecognized tax benefits of $3.2 million for an uncertain tax position associated with a change in accounting method. The unrecognized tax benefits as of December 31, 2023 are timing-related uncertainties that if recognized would not impact the effective tax rate of the Company. The Company files income tax returns in the U.S. federal jurisdiction and U.S. state jurisdictions. As of December 31, 2023, the Company is generally no longer subject to U.S. federal tax examinations for tax years prior to 2020 and state tax examinations for tax years prior to 2019 with limited exceptions for net operating losses from 2013 forward. On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was enacted into law and was effective for taxable years beginning after December 31, 2022. The IRA introduced a 15% alternative minimum tax based on the financial statement income of certain large corporations and imposed a 1% excise tax on share repurchases, effective for tax years beginning after December 31, 2022. The IRA did not have a material impact on our financial results for the year ended December 31, 2023. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies As of December 31, 2023, we had contractual commitments o f $3.3 million related to future renovations and technology enhancements to our communities. We expect these amounts to be substantially expended during 2024. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions As of D ecember 31, 2023 , Conversant Investors and affiliates beneficially owned approximately 63% of our outstanding shares of common sto ck (inclusive of common stock issuable upon conversion of outstanding Series A Preferred Stock and outstanding warrants). O n June 29, 2023, the Company entered into a $13.5 million Equity Commitment agreement with Conversant. The Equity Commitment had a commitment fee of $675,000 payable through the issuance of 67,500 shares of common stock of the Company. The commitment fee shares were issued to Conversant on June 29, 2023. The Company has the right, but not the obligation, to utilize Conversant's equity commitment and may draw on the commitment in whole or in part. The Company made equity draws of $6.0 million in July 2023 and $4.0 million in November 2023 against the equity commitment. On February 1, 2024, the Conversant Investors purchased an additional 2.1 million shares of common stock of the Company for $20.0 million. See “ |
Fair Value
Fair Value | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Fair Value Assets and Liabilities Measured at Fair Value on a Recurring Basis The Company uses interest rate cap arrangements with financial institutions to manage exposure to interest rate changes for loans that utilize floating interest rates. As of December 31, 2023 , we had interest rate cap agreements with an aggregate notional value of $138.4 million . The fair value of these derivative assets as of December 31, 2023 was $2.1 million and was determined using significant observable inputs (Level 2), including quantitative models that utilize multiple market inputs to value the position. The majority of market inputs are actively quoted and can be validated through external sources, including brokers, market transactions and third-party pricing services. See “Note 14 – Derivatives and Hedging . ” Financial Instruments Not Reported at Fair Value For those financial instruments not carried at fair value, the carrying amount and estimated fair values of our financial assets and liabilities were as follows as of December 31, 2023 and December 31, 2022 (in thousands): December 31, 2023 2022 Carrying Fair Value Carrying Fair Value Cash and cash equivalents $ 4,082 $ 4,082 $ 16,913 $ 16,913 Restricted cash 13,668 13,668 13,829 13,829 Notes payable, excluding deferred loan costs 633,783 597,266 676,298 638,485 We believe the carrying amount of cash and cash equivalents, restricted cash, accounts receivable, and accounts payable and accrued liabilities approximate fair value due to their short-term nature. The fair value of notes payable, excluding deferred loan costs, is estimated using discounted cash flow analysis, based on current incremental borrowing rates for similar types of borrowing arrangements, which represent Level 2 inputs as defined in ASC 820 , Fair Value Measurement. Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis The Company may adjust the carrying amount of certain non-financial assets to fair value on a non-recurring basis when they are impaired. During the year ended December 31, 2023, the Company recorded a non-cash impairment charge of $6.0 million to "Property and equipment, net". The fair value of the impaired assets was $7.3 million as of December 31, 2023. During the year ended December, 31, 2022, the Company recorded non-cash impairment charges of $1.6 million related to management's commitment to a plan to sell the community shortly after the balance sheet date, and the agreed-upon selling price being below the community's carrying amount. The fair value of the impaired assets was $0.9 million as of December 31, 2022. The following methods and assumptions were used in estimating its fair value disclosures for financial instruments: Cash and cash equivalents and Restricted cash: The carrying amounts reported in the Company’s Consolidated Balance Sheets for cash and cash equivalents and restricted cash approximate fair value, which represent Level 1 inputs as defined in the accounting standards codification. Notes payable, excluding deferred loan costs: The fair value of notes payable, excluding deferred loan costs, is estimated using discounted cash flow analysis, based on current incremental borrowing rates for similar types of borrowing arrangements, which represent Level 2 inputs as defined in the accounting standards codification. Property and Equipment, Net: During the years ended December 31, 2023 and 2022, the Company evaluated property, plant and equipment, net for impairment and identified properties with a carrying amount of the assets in excess of the estimated future undiscounted net cash flows expected to be generated by the assets. The Company compared the estimated fair value of the assets to their carrying amount for these identified properties and recorded an impairment charge for the excess of carrying amount over fair value. The estimated fair value of these assets and liabilities could be affected by market changes and this effect could be material. |
Derivatives and Hedging
Derivatives and Hedging | 12 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives and Hedging | Derivatives and Hedging The Company uses derivatives as part of our overall strategy to manage our exposure to market risks associated with the fluctuations in interest rates. We are also required to enter into interest rate derivative instruments in compliance with certain debt agreements. We do not enter into derivative financial instruments for trading or speculative purposes. On March 1, 2022, the Company entered into an interest rate cap agreement for an aggregate notional amount of $50.3 million to reduce exposure to interest rate fluctuations associated with a portion of our variable mortgage notes payable. The interest rate cap agreement has a 24-month term and caps the interest rate at 4.00% from March 1, 2022 through March 1, 2024 with respect to the portion of our floating rate indebtedness. LIBOR rates were no longer available after June 30, 2023, as a result this derivative instrument has transitioned to the SOFR rate. In the event SOFR is less than the capped rate, we will pay interest at the lower SOFR rate. In the event SOFR is higher than the capped rate, we will pay interest at the capped rate of 4.00%. The interest rate cap is not designated as a cash flow hedge under ASC 815-20, Derivatives - Hedging , therefore all changes in the fair value of the instrument are included as a component of interest expense in the consolidated statements of operations. On November 30, 2022, in order to comply with the lender’s requirements under the Ally Bank Refinance Facility (see "Note 7–Notes Payable"), the Company entered into a SOFR-based interest rate cap transaction for an aggregate notional amount of $88.1 million at a cost of $2.4 million. The interest rate cap agreement had a 12-month term and effectively capped the interest rate at 2.25% with respect to the portion of our floating rate indebtedness. On December 1, 2023, the Company entered into a new SOFR-based interest rate cap transaction for an aggregate notional amount of $88.1 million at a cost of $2.4 million. The interest rate cap agreement has a 12-month term and effectively caps the interest rate at 2.25% with respect to the portion of our floating rate indebtedness. The interest rate caps are not designated as hedges under ASC 815-20, Derivatives - Hedging , and all changes in the fair value of the instrument are included as a component of interest expense in the consolidated statements of operations. As of December 31, 2023, all of our variable-rate debt obligations were covered by interest rate cap transactions. The following table presents the fair values of derivative assets and liabilities in the consolidated balance sheets (in thousands): December 31, 2023 Derivative Asset Derivative Liability Notional Amount Fair Value Notional Amount Fair Value Interest rate cap ( SOFR-based ) 138,385 2,103 — $ — Total derivatives $ 138,385 $ 2,103 $ — $ — December 31, 2022 Derivative Asset Derivative Liability Notional Amount Fair Value Notional Amount Fair Value Interest rate cap ( LIBOR-based ) $ 50,260 $ 542 $ — $ — Interest rate cap ( SOFR-based ) 88,125 2,180 — $ — Total derivatives $ 138,385 $ 2,722 $ — $ — The following table presents the effect of the derivative instrument on the consolidated statements of operations (in thousands): Years ended December 31, 2023 2022 Derivatives not designated as hedges Interest rate caps Gain (loss) on derivatives not designated as hedges included in interest expense (2,981) 19 |
Allowance for Doubtful Accounts
Allowance for Doubtful Accounts | 12 Months Ended |
Dec. 31, 2023 | |
Receivables [Abstract] | |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts The components of the allowance for doubtful accounts are as follows (in thousands): December 31, 2023 2022 Balance at beginning of year $ 5,915 $ 4,723 Provision for bad debts, net of recoveries 1,151 1,159 Write-offs and other (1,810) 33 Balance at end of year $ 5,256 $ 5,915 Accounts receivable are reported net of an allowance for doubtful accounts to represent the Company’s estimate of inherent losses at the balance sheet date. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events 2024 Private Placement Transaction On February 1, 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with affiliates of Conversant Capital and several other shareholders (together, the “Investors”), pursuant to which the Investors agreed to purchase from the Company, and the Company agreed to sell to the Investors, in a private placement transaction (the “2024 Private Placement”) pursuant to the Securities Act, an aggregate of 5,026,318 shares (the “Shares”) of the Company’s Common Stock, par value $0.01 per share, at a price of $9.50 per share. The 2024 Private Placement occurred in two tranches. The first tranche occurred on February 1, 2024, in which 3,350,878 Shares were issued and sold to the Investors for a total of approximately $31.8 million. The second tranche occurred on March 22, 2024, in which 1,675,440 Shares were issued and sold to the Investors for a total of approximately $15.9 million. The second tranche was following receipt of stockholders approval of the Company’s Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of Common Stock by an additional 15,000,000 shares (the “Stockholder Approval”) and other customary closing conditions. The Stockholder Approval was obtained on March 21, 2024. The Company intends to use this new capital for working capital, continued investments in community improvements, acquisitions of new communities, and broader community programming. Protective Life Loans On February 2, 2024, the Company used a portion of the proceeds from the first equity offering to purchase all seven of the remaining loans held by Protective Life with a total outstanding principal balance of $74.4 million at a purchase price of $40.2 million. Additional financing of $24.8 million for the debt purchase was provided by Ally Bank through an expansion of the Company’s existing Ally Bank term loan, see below. In addition to its aggregate deposits of $1.5 million made in December 2023 and January 2024, the Company funded the remaining cash portion of the purchase price (including one-time closing costs) with approximately $15.4 million of net proceeds from the sale of the Shares at the first closing of the 2024 Private Placement. Ally Term Loan Expansion |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and related footnotes. Management bases its estimates and assumptions on historical experience, observance of industry trends and various other sources of information and factors, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates. |
Cash and Cash Equivalents and Restricted Cash | Cash and Cash Equivalents and Restricted Cash |
Long-Lived Assets and Impairment | Long-Lived Assets and Impairment Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful lives of the assets. At each balance sheet date, the Company reviews the carrying value of its property and equipment to determine if facts and circumstances suggest that they may be impaired or that the depreciation period may need to be changed. The Company considers internal factors, such as net operating losses, along with external factors relating to each asset, including contract changes, local market developments, and other publicly available information to determine whether impairment indicators exist. If an indicator of impairment is identified, recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company estimates fair value of the asset group and records an impairment loss when the carrying amount exceeds fair value. The Company recognized a non-cash impairment charges of $6.0 million to its "Property and equipment, net" during the year ended December 31, 2023, which related to one owned community. The Company recognized non-cash impairment charges of $1.6 million to its “ Property and equipment, net ” during the year ended December 31, 2022, which related to one owned community. See "Note 4–Impairment of Long-Lived Assets". In evaluating our long-lived assets for impairment, we undergo continuous evaluations of property level performance and real estate trends, and management makes several estimates and assumptions, including, but not limited to, the projected date of disposition, estimated sales price and future cash flows of each property during our estimated holding period. If our analysis or assumptions regarding the projected cash flows expected to result from the use and eventual disposition of our properties change, we incur additional costs and expenses during the holding period, or our expected hold periods change, we may incur future impairment losses. Upon the acquisition of new communities accounted for as an acquisition of assets, we recognize the assets acquired and the liabilities assumed as of the acquisition date, measured at their relative fair values once we have determined the fair value of each of these assets and liabilities. The acquisition date is the date on which we obtain control of the real estate property. The assets acquired and liabilities assumed consist of land, inclusive of associated rights, buildings, assumed debt, and identified intangible assets and liabilities. |
Fair Value Measurement | Fair Value Measurement The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2 Inputs – Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 Inputs – Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. The Company's other financial instruments consist primarily of cash and cash equivalents, receivables, accounts payable, accrued expenses, derivative financial instruments, and long-term debt. The carrying value of the Company’s receivables, trade payables, and accrued expenses approximates fair value due to their highly liquid nature, short-term maturity, or competitive rates assigned to these financial instruments. See “Note 13 – Fair Value.” The Company adjusts the carrying amount of certain non-financial assets to fair value on a non-recurring basis when they are impaired. |
Derivatives and Hedging | Derivatives and Hedging |
Stock-based Plans | Stock-based Plans The Company applies the provisions of ASC 718, Compensation - Stock Compensation , in its accounting and reporting for stock-based compensation. ASC 718 requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. All unvested options outstanding under the Company's option plans have grant prices equal to the market price of the Company's stock on the dates of grant. Compensation cost for restricted stock and restricted stock units is determined based on the fair market value of the Company's stock at the date of grant. Stock-based compensation expense is generally recognized over the required service period, or over a shorter period when employee retirement eligibility is a factor. The Company recognizes forfeitures as they occur. |
Advertising Costs | Advertising Costs |
Income Taxes | Income Taxes Income taxes are computed using the asset and liability method and current income taxes are recorded based on amounts refundable or payable in the current year. The effective tax rates for fiscal year 2023 and 2022 differ from the statutory tax rates due to state income taxes, permanent tax differences, and changes in the deferred tax asset valuation allowance. Deferred income taxes are recorded based on the estimated future tax effects of loss carryforwards and temporary differe nces betw een financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the years in which the Company expects those carryforwards and temporary differences to be recovered or settled. Management regularly evaluates the future realization of deferred tax assets and provides a valuation allowance, if considered necessary, based on such evaluation. As part of the evaluation, management has evaluated taxable income in carryback years, future reversals of taxable temporary differences, feasible tax planning strategies, and future expectations of income. The Company evaluates uncertain tax positions through consideration of accounting and reporting guidance on criteria, measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition that is intended to provide better financial statement comparability among different companies. The Company is required to recognize a tax benefit in its financial statements for an uncertain tax position only if management’s assessment is that its position is “more likely than not” (i.e., a greater than 50 percent likelihood) to be upheld on audit based only on the technical merits of the tax position. The Company’s policy is to recognize interest related to unrecognized tax benefits as interest expense and penalties as income tax expense. |
Revenue Recognition | Revenue Recognition Resident revenue consists of fees for basic housing and certain support services and fees associated with additional housing and expanded support requirements such as assisted living care, memory care, and ancillary services. Basic housing and certain support services revenue is recorded when services are rendered, and amounts billed are due from residents in the period in which the rental and other services are provided. Residency agreements are generally short term in nature with durations of one year or less and are typically terminable by either party, under certain circumstances, upon providing 30 days’ notice, unless state law provides otherwise, with resident fees billed monthly in advance. Revenue for certain ancillary services is recognized as services are provided, and includes fees for services such as medication management, daily living activities, beautician/barber, laundry, television, guest meals, pets, and parking which are generally billed monthly in arrears. Other operating revenue consists of state relief funds received from various states due to the financial distress impacts of COVID-19 ("State Relief Funds"). The Company's senior housing communities have residency agreements that generally require the resident to pay a community fee and other amounts prior to moving into the community, which are initially recorded by the Company as deferred revenue. The Company had contract liabilities for deferred fees paid by our residents prior to the month housing and support services were to be provided totaling approximately $4.0 million and $3.4 million, respectively, which is reported as deferred income within current liabilities of the Company’s Consolidated Balance Sheets as of December 31, 2023 and 2022. Revenues from the Medicaid program accounted for approximately 10.4% and 10.0% of the Company’s revenue in fiscal years 2023 and 2022, respectively. During fiscal years 2023 and 2022, 24 and 24, respectively, of the Company’s communities were providers of services under the Medicaid program. Accordingly, these communities were entitled to reimbursement under the Medicaid program at established rates that were lower than private pay rates. Resident revenues for Medicaid residents were recorded at the reimbursement rates as the rates were set prospectively by the applicable state upon the filing of an annual cost report. None of the Company’s communities were providers of services under the Medicare program during fiscal years 2023 or 2022. Laws and regulations governing the Medicaid program are complex and subject to interpretation. The Company believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on its Consolidated Financial Statements. While no such regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties and exclusion from the Medicaid program. The Company has management agreements whereby it manages certain communities on behalf of third-party owners under contracts that provide for periodic management fee payments to the Company. The Company has determined that all community management activities are a single performance obligation, which is satisfied over time as the services are rendered. The Company’s estimate of the transaction price for management services also includes the amount of reimbursement due from the owners of the communities for services provided and related costs incurred. Such revenue is included in “managed community reimbursement revenue” on the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss). The related costs are included in “managed community reimbursement expense” on the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss). Revenue for the years ended December 31, 2023 and 2022 is comprised of the following components (in thousands): Years Ended December 31, 2023 2022 Housing and support services $ 226,148 $ 204,349 Community fees 1,775 1,898 Ancillary services 1,183 1,243 Other operating revenue (1) 2,926 1,213 Resident revenue 232,032 208,703 Management fees 2,191 2,359 Managed community reimbursement revenue 21,099 27,371 Total revenues $ 255,322 $ 238,433 ________ (1) Other operating revenue consists of State Relief Funds received from state departments due to financial distress impacts of COVID-19. For the years ended December 31, 2023 and 2022, the Company received approximately $2.9 million and $1.2 million in various State Relief Funds from state departments due to financial distress impacts of COVID-19. The Company received approximately $9.1 million for the year ended December 31, 2022 through grants from the Public Health and Social Services Emergency Fund’s (the “Provider Relief Fund”) Phase 4 General Distribution, which was expanded by the CARES Act to provide grants or other funding mechanisms to eligible healthcare providers for healthcare-related or lost revenues attributable to COVID-19. The Company recognizes income for government grants on a systematic and rational basis over the periods in which the Company recognizes the related expenses or loss of revenue for which the grants are intended to compensate when there is reasonable assurance that the Company will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. The Phase 4 Provider Relief Funds received from the Federal Government were recorded in “other income (expense), net” and the State Relief Funds were recorded as “resident revenue – other operating revenue” in the Company’s consolidated financial statements and notes thereto. |
Credit Risk and Allowance for Doubtful Accounts | Credit Risk and Allowance for Doubtful Accounts The Company’s resident receivables are generally due within 30 days after the date billed. Accounts receivable are reported net of an allowance for doubtful accounts of $5.3 million and $5.9 million as of December 31, 2023 and 2022, respectively, and represent the Company’s estimate of the amount that ultimately will be collected. The adequacy of the Company’s allowance for doubtful accounts is reviewed on an ongoing basis, using historical payment trends, write-off experience, analyses of receivable portfolios by payor source and aging of receivables, as well as a review of specific accounts, and adjustments are made to the allowance, as necessary. Credit losses on resident receivables have historically been within management’s estimates, and management believes that the allowance for doubtful accounts adequately provides for expected losses. |
Concentration of Credit Risk and Business Risk | Concentration of Credit Risk and Business Risk |
Self-Insurance Liability Accruals | Self-Insurance Liability Accruals The Company offers full-time employees an option to participate in its health and dental plans. The Company is self-insured up to certain limits and is insured if claims in excess of these limits are incurred. The cost of employee health and dental benefits, net of employee contributions, is shared between the corporate office and the senior housing communities based on the respective number of plan participants. Contributions collected are used to pay the actual program costs, including estimated annual claims, third-party administrative fees, network provider fees, communication costs, and other related administrative costs incurred by the plans. Claims are paid as they are submitted to the Company’s third-party administrator. The Company records a liability for outstanding claims and claims that have been incurred but not yet reported. This liability is based on the historical claim reporting lag and payment trends of health insurance claims. Additionally, the Company may be liable for an Employee Shared Responsibility Payment (“ESRP”) pursuant to the Patient Protection and Affordable Care Act. The ESRP is applicable to employers that (i) had 50 or more full-time equivalent employees, (ii) did not offer minimum essential coverage (“MEC”) to at least 70% of full-time employees and their dependents, or (iii) did offer MEC to at least 70% of full-time employees and their dependents that did not meet the affordable or minimum value criteria and had one or more full-time employees certified as being allowed the premium tax credit. The Internal Revenue Service (“IRS”) determines the amount of the proposed ESRP from information returns completed by employers and from income tax returns completed by such employers' employees. Management believes that the recorded liabilities and reserves established for outstanding losses and expenses are adequate to cover the ultimate cost of losses and expenses incurred as of December 31, 2023. It is possible that actual claims and expenses may differ from established reserves. Any subsequent changes in estimates are recorded in the period in which they are determined. The Company uses a combination of insurance and self-insurance for workers’ compensation. Determining the reserve for workers’ compensation losses and costs that the Company has incurred as of the end of a reporting period involves significant judgments based on projected future events, including among other factors, potential settlements for pending claims, known incidents which may result in claims, estimates of incurred but not yet reported claims, changes in insurance premiums and estimated litigation costs. The Company regularly adjusts these estimates to reflect changes in the foregoing factors. However, since this reserve is based on estimates, it is possible the actual expenses incurred may differ from the amounts reserved. Any subsequent changes in estimates are recorded in the period in which they are determined. |
Net Income (Loss) Per Share | Net Income (Loss) Per Common Share The Company uses the two-class method to compute net income (loss) per common share because the Company has issued securities (Series A Preferred Stock) that entitle the holder to participate in dividends and earnings of the Company. Under this method, net income is reduced by the amount of any dividends earned during the period. The remaining earnings (undistributed earnings) are allocated based on the weighted-average shares outstanding of common stock and Series A Preferred Stock (on an if-converted basis) to the extent that each preferred security may share in earnings as if all of the earnings for the period had been distributed. The total earnings allocated to common stock is then divided by the number of outstanding shares to which the earnings are allocated to determine the earnings per share. The two-class method is not applicable during periods with a net loss, as the holders of the Series A Preferred Stock have no obligation to fund losses. Diluted net income (loss) per common share is computed under the two-class method by using the weighted-average number of shares of common stock outstanding, plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options, stock based compensation awards and warrants. In addition, the Company analyzes the potential dilutive effect of the outstanding Series A Preferred Stock under the “if-converted” method when calculating diluted earnings per share, in which it is assumed that the outstanding Series A Preferred Stock converts into common stock at the beginning of the period or when issued, if later. The Company reports the more dilutive of the approaches (two class or “if-converted”) as its diluted net income per share during the period. |
Redeemable Preferred Stock | Redeemable Preferred Stock The Company's Series A Preferred Stock is convertible outside of our control and in accordance with ASC 480-10-S99-3A and as such is classified as mezzanine equity. The Series A Preferred Stock was initially recorded at fair value upon issuance, net of issuance costs and discounts. The holders of our Series A Preferred Stock are Conversant Parkway (A) LP (“Conversant A”) and Conversant Parkway (B) LP (“Conversant B” and, together with Conversant A, “Conversant” or “Conversant Investors”), and are entitled to vote with the holders of common stock on all matters submitted to a vote of stockholders of the Company. As such, the Conversant Investors, in combination with their common stock ownership as of December 31, 2023 and 2022, have voting rights in excess of 50% of the Company’s total voting stock. It is deemed probable that the Series A Preferred Stock could be redeemed for cash by the Conversant Investors, and as such the Series A Preferred Stock is required to be remeasured and adjusted to its maximum redemption value at the end of each reporting period. However, to the extent that the maximum redemption value of the Series A Preferred Stock does not exceed the fair value of the shares at the date of issuance, the shares are not adjusted below the fair value at the date of issuance. As of December 31, 2023 and December 31, 2022, the Series A Preferred Stock is carried at the maximum redemption value. |
Segment Information | Segment Information The Company evaluates the performance of its senior living communities and allocates resources based on current operations and market assessments on a property-by-property basis. The Company does not have a concentration of operations geographically or by product or service as its management functions are integrated at the property level. The Company has determined that its operating units meet the criteria in ASC Topic 280, Segment Reporting , to be aggregated into one reporting segment. As such, the Company operates in one segment. |
Troubled Debt Restructurings | Troubled Debt Restructurings |
Reclassifications | Reclassifications Certain amounts previously reflected in the prior year consolidated financial statements have been reclassified to conform to our December 31, 2023 presentation. |
Off-Balance Sheet Arrangements | Off-Balance Sheet Arrangements The Company had no material off-balance sheet arrangements as of December 31, 2023 or 2022. |
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted | Recently Adopted Accounting Pronouncements Allowance for Doubtful Account s In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments . Current GAAP requires an “incurred loss” methodology for recognizing credit losses that delays recognition until it is probable a loss has been incurred. ASU 2016-13 replaces the current incurred loss methodology for credit losses and removes the thresholds that companies apply to measure credit losses on financial statements measured at amortized cost, such as loans, receivables, and held-to-maturity debt securities with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to form credit loss estimates. The determination of the allowance for credit losses under the new standard would typically be based on evaluation of a number of factors, including, but not limited to, general economic conditions, payment status, historical collection patterns and loss experience, financial strength of the borrower, and nature, extent and value of the underlying collateral. For smaller reporting companies, ASU 2016-13 is effective for fiscal years and for interim periods within those fiscal years beginning after December 15, 2022. It requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. The Company adopted ASU 2016-13 on January 1, 2023. The effect of the adoption had an immaterial impact on our consolidated financial statements. Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on contracts, hedging relationships, and other transactions that reference the London InterBank Offered Rate. The new standard was effective upon issuance and elections can be made through December 31, 2022. The adoption of the optional expedient has not had and is not expected to have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted Segment Reporting In November of 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The ASU is effective on a retrospective basis for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on the disclosures within the Company's consolidated financial statements. Income Tax Disclosures In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The amendments require disclosure of specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold and further disaggregation of income taxes paid for individually significant jurisdictions. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact that this guidance will have on the disclosures within the Company's consolidated financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Cash and Cash Equivalents and Restricted Cash | The following table sets forth our cash and cash equivalents and restricted cash (in thousands): Years Ended December 31, 2023 2022 Cash and cash equivalents $ 4,082 $ 16,913 Restricted cash: Property tax and insurance reserves 7,237 6,184 Lender reserve 3,329 1,500 Capital expenditures reserves 2,060 2,034 Escrow deposit 1,000 — Deposits pursuant to outstanding letters of credit 42 4,111 Total restricted cash 13,668 13,829 Total cash, cash equivalents, and restricted cash $ 17,750 $ 30,742 |
Disaggregation of Revenue | Revenue for the years ended December 31, 2023 and 2022 is comprised of the following components (in thousands): Years Ended December 31, 2023 2022 Housing and support services $ 226,148 $ 204,349 Community fees 1,775 1,898 Ancillary services 1,183 1,243 Other operating revenue (1) 2,926 1,213 Resident revenue 232,032 208,703 Management fees 2,191 2,359 Managed community reimbursement revenue 21,099 27,371 Total revenues $ 255,322 $ 238,433 ________ |
Schedule of Computation of Basic and Diluted Net Loss Per Share | The following table sets forth the computation of basic and diluted net loss per common share (in thousands, except for per share amounts): Years Ended December 31, 2023 2022 Basic net loss per common share calculation: Net loss $ (21,107) $ (54,401) Less: Dividends on Series A Preferred Stock — (2,269) Less: Undeclared dividends on Series A Preferred Stock (4,992) (2,300) Net loss attributable to common stockholders $ (26,099) $ (58,970) Weighted average shares outstanding — basic 6,786 6,359 Basic net loss per share $ (3.85) $ (9.27) Diluted net loss per common share calculation: Net loss attributable to common stockholders $ (26,099) $ (58,970) Weighted average shares outstanding — diluted 6,786 6,359 Diluted net loss per share $ (3.85) $ (9.27) |
Schedule of Weighted-Average Shares Not Included in Computation of Net Income (Loss) per Share | The following weighted-average shares of securities were not included in the computation of diluted net loss per common share as their effect would have been antidilutive: Years Ended December 31, (shares in thousands) 2023 2022 Series A Preferred Stock (if converted) 1,150 1,089 Warrants 1,031 1,031 Restricted stock awards 661 382 Restricted stock units 2 — Stock options 10 10 Total 2,854 2,512 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Net Property and Equipment and Leasehold Improvements | As of December 31, 2023 and 2022, property and equipment, net and leasehold improvements, which include assets under finance leases, consists of the following (in thousands): December 31, Asset Lives 2023 2022 Land NA $ 47,173 $ 47,476 Land improvements 5 to 20 years 20,487 20,053 Buildings and building improvements 10 to 40 years 845,873 842,854 Furniture and equipment 5 to 10 years 58,443 53,236 Automobiles 5 to 7 years 2,687 2,704 Leasehold improvements, and assets under finance leases (1) 2,766 1,899 Construction in progress NA 259 666 Total property and equipment $ 977,688 $ 968,888 Less accumulated depreciation and amortization (389,509) (353,134) Property and equipment, net $ 588,179 $ 615,754 _____________________________________ (1) |
Accrued Expenses (Tables)
Accrued Expenses (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Payables and Accruals [Abstract] | |
Schedule of Accrued Expenses | Accrued expenses consist of the following (in thousands): December 31, 2023 2022 Accrued payroll and employee benefits $ 15,639 $ 13,795 Accrued interest (1) 11,316 9,374 Accrued taxes 7,614 6,939 Accrued professional fees 5,022 3,179 Accrued other expenses 2,797 3,657 $ 42,388 $ 36,944 __________ (1) |
Notes Payable (Tables)
Notes Payable (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Notes Payable | Notes payable consists of the following (in thousands): December 31, Weighted average Maturity Date 2023 2022 Fixed rate mortgage notes payable 4.6% 2024 to 2045 $ 492,998 $ 503,312 Fannie Mae - two mortgage notes payable (1) — 31,991 Variable rate mortgage notes payable (2) 5.9% 2026 to 2029 137,320 137,652 Notes payable - insurance 6.4% 2024 1,846 1,724 Notes payable - other 8.5% 2024 1,619 1,619 Notes payable $ 633,783 $ 676,298 Deferred loan costs, net 4,361 5,267 Total notes payable, net of deferred loan costs $ 629,422 $ 671,031 Current portion of notes payable (3) 42,323 46,029 Long-term notes payable, net $ 587,099 $ 625,002 |
Summary of Aggregate Scheduled Maturities of Notes Payable | The following schedule summarizes our notes payable as of December 31, 2023 (in thousands): Principal payments due in (4) : 2024 (3) $ 43,994 2025 34,208 2026 347,847 2027 3,597 2028 3,719 Thereafter 200,418 Total notes payable, excluding deferred loan costs $ 633,783 __________ (1) See “Transactions Involving Certain Fannie Mae Loans” disclosure below. (2) The weighted average interest rate for variable debt is the strike rate under the applicable interest rate cap agreements. See Note 14 for interest rate cap agreements on variable rate mortgage notes payable. (3) December 31 2023 includes $34.2 million aggregate outstanding principal due under the loans with Protective Life Insurance Company. See “Protective Life Insurance Company Non-recourse Mortgages” disclosure below. (4) Includes maturities of the subsequent refinancing that occurred with Ally Bank in February 2024. |
Securities Financing (Tables)
Securities Financing (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Schedule of Changes in Convertible Preferred Stock | Changes in the Series A Preferred Stock are as follows: Series A Preferred Stock Shares Amount (In thousands) Balance as of December 31, 2021 41 $ 41,250 Undeclared dividends on Series A Preferred Stock — 2,300 Balance as of December 31, 2022 41 43,550 Undeclared dividends on Series A Preferred Stock — 4,992 Balance as of December 31, 2023 41 $ 48,542 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Restricted Stock Awards Activity | A summary of restricted stock units’ activity is presented in the table below: Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 12,816 $ 102.20 Granted 8,739 26.50 Vested (12,816) 102.20 Non-vested shares as of December 31, 2022 8,739 $ 26.50 Granted 3,000 8.80 Vested (8,739) 26.50 Non-vested shares as of December 31, 2023 3,000 $ 8.80 Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 112,319 $ 39.51 Granted 70,101 28.14 Forfeited/Cancelled (79,327) 34.99 Vested (21,965) 51.97 Non-vested shares as of December 31, 2022 81,128 $ 30.75 Granted 56,400 7.50 Forfeited/Cancelled (2,913) 26.50 Vested (26,044) 28.72 Non-vested shares as of December 31, 2023 108,571 $ 19.26 Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 — $ — Granted 87,674 28.47 Forfeited/Cancelled (35,055) 31.58 Non-vested shares as of December 31, 2022 52,619 $ 26.40 Granted 96,600 7.03 Non-vested shares as of December 31, 2023 149,219 $ 13.86 A summary of market-based restricted stock awards’ activity is presented in the table below: Number of Shares Weighted Average Grant-Date Fair Value Non-vested shares as of January 1, 2022 188,411 $ 28.20 Granted 60,039 23.19 Converted to Time-Based (77,100) 27.02 Non-vested shares as of December 31, 2022 171,350 $ 26.97 Granted 293,600 8.12 Non-vested shares as of December 31, 2023 464,950 $ 15.07 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of (Benefit) Provision for Income Taxes | The provision for income taxes consists of the following (in thousands): Years Ended December 31, 2023 2022 Current: Federal $ — $ — State 253 86 Deferred: Federal — — Provision for income taxes $ 253 $ 86 |
Schedule of Provision (Benefit) for Income Taxes by Statutory Income Tax Rate | The provision for income taxes differed from the amounts of income tax (benefit) provision determined by applying the U.S. federal statutory income tax rate to income before (benefit) provision for income taxes as a result of the following (in thousands): Years Ended December 31, 2023 2022 Tax (benefit) provision at federal statutory rates $ (4,374) $ (11,407) State income tax (benefit) provision, net of federal effects 520 (716) Change in deferred tax asset valuation allowance 1,566 11,253 Stock based compensation expense 335 457 Permanent impact of employee retention credit claims 2,302 — Other (96) 499 Provision for income taxes $ 253 $ 86 |
Summary of Deferred Tax Assets and Liabilities | A summary of the Company’s deferred tax assets and liabilities, are as follows (in thousands): December 31, 2023 2022 Deferred tax assets: Lease liabilities $ 377 $ 413 Net operating loss carryforward 92,251 84,899 Compensation costs 3,233 2,491 Depreciation and amortization 1,884 9 Other 3,119 11,526 Total deferred tax assets 100,864 99,338 Deferred tax asset valuation allowance (100,838) (99,273) Total deferred tax assets, net 26 65 Deferred tax liabilities: Operating lease right-of-use assets (26) (65) Total deferred tax liabilities (26) (65) Deferred taxes, net $ — $ — |
Schedule of Unrecognized Tax Benefits Activity and Related Information | A summary of the Company’s unrecognized tax benefits activity and related information for the years ended December 31, 2023 and 2022 is presented below (in thousands): Years Ended December 31, 2023 2022 Beginning balance, January 1 $ 2,796 $ 2,383 Gross increases – tax positions in prior period 397 413 Ending balance, December 31 $ 3,193 $ 2,796 |
Fair Value (Tables)
Fair Value (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Carrying Amounts and Fair Values of Financial Instruments | For those financial instruments not carried at fair value, the carrying amount and estimated fair values of our financial assets and liabilities were as follows as of December 31, 2023 and December 31, 2022 (in thousands): December 31, 2023 2022 Carrying Fair Value Carrying Fair Value Cash and cash equivalents $ 4,082 $ 4,082 $ 16,913 $ 16,913 Restricted cash 13,668 13,668 13,829 13,829 Notes payable, excluding deferred loan costs 633,783 597,266 676,298 638,485 |
Derivatives and Hedging (Tables
Derivatives and Hedging (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The following table presents the fair values of derivative assets and liabilities in the consolidated balance sheets (in thousands): December 31, 2023 Derivative Asset Derivative Liability Notional Amount Fair Value Notional Amount Fair Value Interest rate cap ( SOFR-based ) 138,385 2,103 — $ — Total derivatives $ 138,385 $ 2,103 $ — $ — December 31, 2022 Derivative Asset Derivative Liability Notional Amount Fair Value Notional Amount Fair Value Interest rate cap ( LIBOR-based ) $ 50,260 $ 542 $ — $ — Interest rate cap ( SOFR-based ) 88,125 2,180 — $ — Total derivatives $ 138,385 $ 2,722 $ — $ — |
Schedule of Derivative Instruments | The following table presents the effect of the derivative instrument on the consolidated statements of operations (in thousands): Years ended December 31, 2023 2022 Derivatives not designated as hedges Interest rate caps Gain (loss) on derivatives not designated as hedges included in interest expense (2,981) 19 |
Allowance for Doubtful Accoun_2
Allowance for Doubtful Accounts (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Receivables [Abstract] | |
Schedule of Allowance for Doubtful Accounts | The components of the allowance for doubtful accounts are as follows (in thousands): December 31, 2023 2022 Balance at beginning of year $ 5,915 $ 4,723 Provision for bad debts, net of recoveries 1,151 1,159 Write-offs and other (1,810) 33 Balance at end of year $ 5,256 $ 5,915 |
Organization and Business (Deta
Organization and Business (Detail) resident in Thousands, $ in Thousands | 1 Months Ended | ||
Feb. 01, 2022 USD ($) seniorHousingCommunity | Aug. 31, 2023 USD ($) | Dec. 31, 2023 seniorHousingCommunity state resident | |
Real Estate Properties [Line Items] | |||
Number of senior housing communities | 71 | ||
Number of states with senior housing communities | state | 18 | ||
Aggregate capacity of residents in senior housing communities | resident | 8 | ||
Proceeds from sale of property, plant, and equipment | $ | $ 1,000 | ||
Loss on sale of assets, net | $ | $ 200 | ||
Senior Living Communities Located in Indiana | |||
Real Estate Properties [Line Items] | |||
Number of communities acquired | 2 | ||
Purchase price of communities acquired | $ | $ 12,300 | ||
Number of living units in a housing community | 157 | ||
Wholly Owned Properties | |||
Real Estate Properties [Line Items] | |||
Number of senior housing communities | 61 | ||
Managed On Behalf Of Third Parties | |||
Real Estate Properties [Line Items] | |||
Number of senior housing communities | 10 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents and Restricted Cash (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Restricted Cash and Cash Equivalents Items [Line Items] | |||
Cash and cash equivalents | $ 4,082 | $ 16,913 | |
Restricted cash | 13,668 | 13,829 | |
Total cash, cash equivalents, and restricted cash | 17,750 | 30,742 | $ 92,876 |
Property tax and insurance reserves | |||
Restricted Cash and Cash Equivalents Items [Line Items] | |||
Restricted cash | 7,237 | 6,184 | |
Lender reserve | |||
Restricted Cash and Cash Equivalents Items [Line Items] | |||
Restricted cash | 3,329 | 1,500 | |
Capital expenditures reserves | |||
Restricted Cash and Cash Equivalents Items [Line Items] | |||
Restricted cash | 2,060 | 2,034 | |
Escrow deposit | |||
Restricted Cash and Cash Equivalents Items [Line Items] | |||
Restricted cash | 1,000 | 0 | |
Deposits pursuant to outstanding letters of credit | |||
Restricted Cash and Cash Equivalents Items [Line Items] | |||
Restricted cash | $ 42 | $ 4,111 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Narrative (Detail) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 USD ($) segment property seniorHousingCommunity | Dec. 31, 2022 USD ($) seniorHousingCommunity | Dec. 31, 2021 USD ($) | |
Accounting Policies [Line Items] | |||
Long-lived asset impairment | $ 5,965 | $ 1,588 | |
Number of impaired communities | seniorHousingCommunity | 1 | 1 | |
Advertising expense | $ 1,500 | $ 1,600 | |
Grant revenue | $ 2,900 | 1,200 | |
Grants receivable | 9,100 | ||
Resident receivables due period | 30 days | ||
Allowance for doubtful accounts | $ 5,256 | $ 5,915 | $ 4,723 |
Number of senior housing communities | seniorHousingCommunity | 71 | ||
Percentage of voting rights | 0.50 | 0.50 | |
Undeclared dividends on Series A convertible preferred stock | $ 4,992 | $ 2,300 | |
Number of reporting segment | segment | 1 | ||
Number of operating segment | segment | 1 | ||
Undeclared dividends on Series A Preferred Stock | $ 5,000 | 2,300 | |
Convertible Preferred Stock | |||
Accounting Policies [Line Items] | |||
Undeclared dividends on Series A Preferred Stock | $ 5,000 | ||
Properties | Geographic Concentration Risk | Texas | |||
Accounting Policies [Line Items] | |||
Percentage of revenue | 23% | ||
Number of senior housing communities | property | 16 | ||
Properties | Geographic Concentration Risk | Indiana | |||
Accounting Policies [Line Items] | |||
Percentage of revenue | 18% | ||
Number of senior housing communities | property | 12 | ||
Properties | Geographic Concentration Risk | Ohio | |||
Accounting Policies [Line Items] | |||
Percentage of revenue | 20% | ||
Number of senior housing communities | property | 10 | ||
Properties | Geographic Concentration Risk | Wisconsin | |||
Accounting Policies [Line Items] | |||
Percentage of revenue | 10% | ||
Number of senior housing communities | property | 8 | ||
Housing and support services | |||
Accounting Policies [Line Items] | |||
Contract with customer liability | $ 4,000 | $ 3,400 | |
Managed community reimbursement revenue | Revenue Benchmark | Product Concentration Risk | |||
Accounting Policies [Line Items] | |||
Percentage of revenue | 10.40% | 10% | |
Medicaid Program | |||
Accounting Policies [Line Items] | |||
Number of communities providing services under Medicaid and Medicare programs | seniorHousingCommunity | 24 | 24 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disaggregation of Revenue [Line Items] | ||
Revenues | $ 255,322 | $ 238,433 |
Resident revenue | ||
Disaggregation of Revenue [Line Items] | ||
Revenues | 232,032 | 208,703 |
Housing and support services | ||
Disaggregation of Revenue [Line Items] | ||
Revenues | 226,148 | 204,349 |
Community fees | ||
Disaggregation of Revenue [Line Items] | ||
Revenues | 1,775 | 1,898 |
Ancillary services | ||
Disaggregation of Revenue [Line Items] | ||
Revenues | 1,183 | 1,243 |
Other operating revenue | ||
Disaggregation of Revenue [Line Items] | ||
Revenues | 2,926 | 1,213 |
Management fees | ||
Disaggregation of Revenue [Line Items] | ||
Revenues | 2,191 | 2,359 |
Managed community reimbursement revenue | ||
Disaggregation of Revenue [Line Items] | ||
Revenues | $ 21,099 | $ 27,371 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Basic net loss per common share calculation: | ||
Net loss | $ (21,107) | $ (54,401) |
Less: Dividends on Series A Preferred Stock | 0 | (2,269) |
Less: Undeclared dividends on Series A Preferred Stock | (4,992) | (2,300) |
Net loss attributable to common stockholders | $ (26,099) | $ (58,970) |
Weighted average shares outstanding — basic (in shares) | 6,786 | 6,359 |
Basic net loss per share (in USD per share) | $ (3.85) | $ (9.27) |
Diluted net loss per common share calculation: | ||
Net loss attributable to common stockholders | $ (26,099) | $ (58,970) |
Weighted average shares outstanding — diluted (in shares) | 6,786 | 6,359 |
Diluted net loss per share (in USD per share) | $ (3.85) | $ (9.27) |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies - Schedule of Shares Excluded From Computation of Net Loss Per Share (Detail) - shares shares in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Accounting Policies [Line Items] | ||
Antidilutive shares excluded from earnings per share (in shares) | 2,854 | 2,512 |
Series A Preferred Stock (if converted) | ||
Accounting Policies [Line Items] | ||
Antidilutive shares excluded from earnings per share (in shares) | 1,150 | 1,089 |
Warrants | ||
Accounting Policies [Line Items] | ||
Antidilutive shares excluded from earnings per share (in shares) | 1,031 | 1,031 |
Restricted stock awards | ||
Accounting Policies [Line Items] | ||
Antidilutive shares excluded from earnings per share (in shares) | 661 | 382 |
Restricted stock units | ||
Accounting Policies [Line Items] | ||
Antidilutive shares excluded from earnings per share (in shares) | 2 | 0 |
Stock options | ||
Accounting Policies [Line Items] | ||
Antidilutive shares excluded from earnings per share (in shares) | 10 | 10 |
Impairment of Long-Lived Asse_2
Impairment of Long-Lived Assets (Details) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 USD ($) seniorHousingCommunity | Dec. 31, 2022 USD ($) seniorHousingCommunity | |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Long-lived asset impairment | $ | $ 5,965 | $ 1,588 |
Number of impaired communities | seniorHousingCommunity | 1 | 1 |
Discount Rate | Fair Value, Recurring | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Capitalization rate | 0.085 | |
Market Capitalization Rate | Fair Value, Recurring | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Capitalization rate | 0.075 |
Property and Equipment - Schedu
Property and Equipment - Schedule of Net Property and Equipment and Leasehold Improvements (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 977,688 | $ 968,888 |
Less accumulated depreciation and amortization | (389,509) | (353,134) |
Property and equipment, net | 588,179 | 615,754 |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 47,173 | 47,476 |
Land improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 20,487 | 20,053 |
Land improvements | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 5 years | |
Land improvements | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 20 years | |
Buildings and building improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 845,873 | 842,854 |
Buildings and building improvements | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 10 years | |
Buildings and building improvements | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 40 years | |
Furniture and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 58,443 | 53,236 |
Furniture and equipment | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 5 years | |
Furniture and equipment | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 10 years | |
Automobiles | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 2,687 | 2,704 |
Automobiles | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 5 years | |
Automobiles | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Asset Lives | 7 years | |
Leasehold improvements, and assets under finance leases | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 2,766 | 1,899 |
Finance lease assets | 100 | 200 |
Construction in progress | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 259 | $ 666 |
Property and Equipment - Narrat
Property and Equipment - Narrative (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | ||
Non-cash additions of property and equipment | $ 2,355 | $ 1,559 |
Long-lived asset impairment | $ 5,965 | $ 1,588 |
Accrued Expenses (Details)
Accrued Expenses (Details) $ in Thousands | Dec. 31, 2023 USD ($) seniorHousingCommunity | Dec. 31, 2022 USD ($) |
Debt Instrument [Line Items] | ||
Accrued payroll and employee benefits | $ 15,639 | $ 13,795 |
Accrued interest | 11,316 | 9,374 |
Accrued taxes | 7,614 | 6,939 |
Accrued professional fees | 5,022 | 3,179 |
Accrued other expenses | 2,797 | 3,657 |
Accrued expenses | $ 42,388 | $ 36,944 |
Number of senior housing communities | seniorHousingCommunity | 71 | |
Protective Life Insurance Company | ||
Debt Instrument [Line Items] | ||
Accrued interest | $ 3,300 | |
Entity Loan Modification Program | ||
Debt Instrument [Line Items] | ||
Accrued interest | $ 4,300 |
Notes Payable - Schedule of Not
Notes Payable - Schedule of Notes Payable (Detail) $ in Thousands | Dec. 31, 2023 USD ($) seniorHousingCommunity | Dec. 31, 2022 USD ($) |
Debt Instrument [Line Items] | ||
Notes payable | $ 633,783 | $ 676,298 |
Deferred loan costs, net | 4,361 | 5,267 |
Total notes payable, net of deferred loan costs | 629,422 | 671,031 |
Current portion of notes payable | 42,323 | 46,029 |
Long-term notes payable, net | $ 587,099 | 625,002 |
Number of senior housing communities | seniorHousingCommunity | 71 | |
Fixed rate mortgage notes payable | ||
Debt Instrument [Line Items] | ||
Weighted average interest rate | 4.60% | |
Notes payable | $ 492,998 | 503,312 |
Fannie Mae mortgage notes payable | ||
Debt Instrument [Line Items] | ||
Notes payable | $ 0 | 31,991 |
Number of senior housing communities | seniorHousingCommunity | 2 | |
Variable rate mortgage notes payable | ||
Debt Instrument [Line Items] | ||
Weighted average interest rate | 5.90% | |
Notes payable | $ 137,320 | 137,652 |
Notes payable - insurance | ||
Debt Instrument [Line Items] | ||
Weighted average interest rate | 6.38% | |
Notes payable | $ 1,846 | 1,724 |
Total notes payable, net of deferred loan costs | $ 1,800 | |
Notes payable - other | ||
Debt Instrument [Line Items] | ||
Weighted average interest rate | 8.50% | |
Notes payable | $ 1,619 | $ 1,619 |
Notes Payable - Summary of Aggr
Notes Payable - Summary of Aggregate Scheduled Maturities of Notes (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
2024 | $ 43,994 | |
2025 | 34,208 | |
2026 | 347,847 | |
2027 | 3,597 | |
2028 | 3,719 | |
Thereafter | 200,418 | |
Total notes payable, excluding deferred loan costs | 633,783 | $ 676,298 |
Current portion of notes payable | 42,323 | $ 46,029 |
Protective Life Insurance Company | ||
Debt Instrument [Line Items] | ||
Current portion of notes payable | $ 34,200 |
Notes Payable - Fixed Rate Mort
Notes Payable - Fixed Rate Mortgage Notes - Narrative (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Debt Instrument [Line Items] | |
Property and equipment, net | $ 578.4 |
Fixed rate mortgage notes payable | Interest rate cap (SOFR-based) | |
Debt Instrument [Line Items] | |
Debt instrument variable rate at period end | 5.40% |
Minimum | Fixed rate mortgage notes payable | |
Debt Instrument [Line Items] | |
Debt instrument, interest rate effective percentage | 3.60% |
Minimum | Fixed rate mortgage notes payable | Interest rate cap (SOFR-based) | |
Debt Instrument [Line Items] | |
Debt instrument variable interest rate | 2.14% |
Maximum | Fixed rate mortgage notes payable | |
Debt Instrument [Line Items] | |
Debt instrument, interest rate effective percentage | 6.30% |
Maximum | Fixed rate mortgage notes payable | Interest rate cap (SOFR-based) | |
Debt Instrument [Line Items] | |
Debt instrument variable interest rate | 3.50% |
Notes Payable - Fannie Mae Loan
Notes Payable - Fannie Mae Loan Modification - Narrative (Details) | 1 Months Ended | 12 Months Ended | |||
Jun. 01, 2024 USD ($) | Jul. 31, 2023 USD ($) | Dec. 31, 2023 USD ($) property seniorHousingCommunity | Dec. 31, 2022 USD ($) | Jun. 29, 2023 property | |
Debt Instrument [Line Items] | |||||
Number of senior housing communities | seniorHousingCommunity | 71 | ||||
Weighted average interest rate reduction | 0.015 | ||||
Debt transaction costs paid | $ 825,000 | $ 2,361,000 | |||
Forbearance Agreements | Forecast | |||||
Debt Instrument [Line Items] | |||||
Principal payments | $ 5,000,000 | ||||
Forbearance Agreements | Fannie Mae Loan | |||||
Debt Instrument [Line Items] | |||||
Number of senior housing communities | property | 37 | 37 | |||
Principal payments | $ 5,000,000 | ||||
Finance agreement term | 12 months | ||||
Debt instrument effective date | 1 year | ||||
Equity commitment, amount drawn down | $ 10,000,000 | ||||
Equity commitment, amount remaining | 3,500,000 | ||||
Debt restructuring costs | 700,000 | ||||
Debt transaction costs paid | $ 3,100,000 | ||||
Forbearance Agreements | Fannie Mae Loan | Forecast | |||||
Debt Instrument [Line Items] | |||||
Principal payments | $ 5,000,000 | ||||
Finance agreement term | 24 months | ||||
Debt instrument, guaranty | $ 10,000,000 | ||||
Forbearance Agreements | Fannie Mae Loan | Master Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Number of senior housing communities | property | 19 | ||||
Debt term from effective date | 36 months | ||||
Finance agreement term | 12 months | ||||
Debt instrument, covenant, escrow requirement, percent | 0.50 | ||||
Escrow deposit | $ 200,000 | ||||
Forbearance Agreements | Fannie Mae Loan | Fixed rate mortgage notes payable | |||||
Debt Instrument [Line Items] | |||||
Number of senior housing communities | property | 18 |
Notes Payable - Transactions In
Notes Payable - Transactions Involving Certain Fannie Mae Loans - Narrative (Details) $ in Thousands | 12 Months Ended | ||||||
Jul. 31, 2020 USD ($) seniorHousingCommunity | Dec. 31, 2023 USD ($) seniorHousingCommunity | Dec. 31, 2022 USD ($) property | Dec. 31, 2021 property | Jan. 31, 2023 property | Aug. 01, 2020 property | Jul. 31, 2020 property | |
Debt Instrument [Line Items] | |||||||
Number of senior housing communities | seniorHousingCommunity | 71 | ||||||
Current portion of notes payable | $ 42,323 | $ 46,029 | |||||
Accrued interest | 11,316 | 9,374 | |||||
Gain (loss) on extinguishment of debt | 36,339 | $ (641) | |||||
Fannie Mae | |||||||
Debt Instrument [Line Items] | |||||||
Number of properties transferred | property | 16 | ||||||
Fannie Mae Loan | |||||||
Debt Instrument [Line Items] | |||||||
Gain (loss) on extinguishment of debt | $ 36,300 | ||||||
Fannie Mae Loan | Fannie Mae | |||||||
Debt Instrument [Line Items] | |||||||
Number of senior housing communities | property | 2 | 2 | |||||
Current portion of notes payable | $ 31,800 | ||||||
Deferred costs | 200 | ||||||
Accrued interest | $ 4,100 | ||||||
Fannie Mae Loan | Forbearance Agreements | |||||||
Debt Instrument [Line Items] | |||||||
Unpaid loans | $ 3,800 | ||||||
Number of senior housing communities | 18 | 18 | 18 |
Notes Payable - 2023 Ally Loan
Notes Payable - 2023 Ally Loan Amendment - Narrative (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | ||||||||
Dec. 01, 2023 | Jun. 29, 2023 | May 11, 2023 | Dec. 13, 2022 | Nov. 30, 2022 | Jul. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 | Mar. 01, 2022 | |
Debt Instrument [Line Items] | ||||||||||
Payment for derivative instruments | $ 2,362 | $ 2,703 | ||||||||
Interest Rate Cap | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Payment for derivative instruments | $ 2,400 | $ 2,300 | ||||||||
Derivative, term of contract | 12 months | 1 year | ||||||||
Notional amount | $ 88,100 | $ 88,100 | 138,385 | 138,385 | ||||||
Debt instrument variable rate at period end | 4% | |||||||||
Interest Rate Cap | Interest rate cap (SOFR-based) | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Payment for derivative instruments | $ 2,400 | |||||||||
Notional amount | $ 88,100 | 138,385 | $ 88,125 | |||||||
Debt instrument variable rate at period end | 2.25% | 2.25% | 2.25% | |||||||
Forbearance Agreements | Ally Loan, Amendment | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Minimum liquidity covenant | $ 13,000 | |||||||||
Debt instrument, covenant, term | 12 months | |||||||||
Limited payment guaranty waiver threshold | 6,000 | |||||||||
Waiver principal reserve | $ 117 | |||||||||
Refinance Facility | Mortgage Debt | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Minimum liquidity covenant | $ 13,000 | |||||||||
Increase of debt | $ 8,100 | |||||||||
Refinance Facility | Ally Loan, Amendment | Mortgage Debt | ||||||||||
Debt Instrument [Line Items] | ||||||||||
Minimum liquidity covenant | $ 7,000 | |||||||||
Increase of debt | $ 1,000 |
Notes Payable - 2022 Ally Loan
Notes Payable - 2022 Ally Loan Refinance - Narrative (Details) $ in Thousands | 1 Months Ended | 12 Months Ended | ||||
Dec. 13, 2022 USD ($) subsidiary | Mar. 31, 2022 USD ($) seniorHousingCommunity | Dec. 31, 2023 USD ($) seniorHousingCommunity | Dec. 31, 2022 USD ($) | Mar. 31, 2023 USD ($) | Nov. 30, 2022 USD ($) | |
Debt Instrument [Line Items] | ||||||
Other assets, net | $ 936 | $ 1,837 | ||||
Amortization of deferred loan costs | 1,552 | 1,281 | ||||
Gain (loss) on extinguishment of debt | 36,339 | $ (641) | ||||
Number of subsidiaries added as borrowers | subsidiary | 2 | |||||
Refinance Facility | ||||||
Debt Instrument [Line Items] | ||||||
Deferred financing costs, net | $ 2,200 | |||||
Amortization of deferred loan costs | 1,000 | |||||
Refinance Facility | Mortgage Debt | ||||||
Debt Instrument [Line Items] | ||||||
Number of properties securing loan | seniorHousingCommunity | 10 | |||||
Note principal amount | $ 88,100 | $ 80,000 | $ 88,100 | |||
Minimum tangible net worth covenant | 150,000 | |||||
Minimum liquidity covenant | 13,000 | |||||
Other assets, net | $ 1,500 | |||||
Gain (loss) on extinguishment of debt | $ (600) | |||||
Increase of debt | $ 8,100 | |||||
Number of communities | seniorHousingCommunity | 12 | |||||
Refinance Facility | Mortgage Debt | Covenant achievement, scenario one | ||||||
Debt Instrument [Line Items] | ||||||
Limited payment guaranty percentage | 0.33 | |||||
Refinance Facility | Mortgage Debt | Covenant achievement, scenario two | ||||||
Debt Instrument [Line Items] | ||||||
Limited payment guaranty percentage | 0.25 | |||||
Refinance Facility | Mortgage Debt | Covenant achievement, scenario three | ||||||
Debt Instrument [Line Items] | ||||||
Limited payment guaranty percentage | 0.10 |
Notes Payable - Protective Life
Notes Payable - Protective Life Insurance Company Non-recourse Mortgages - Narrative (Details) $ in Thousands | 12 Months Ended | |||
Feb. 02, 2024 USD ($) property | Dec. 31, 2023 USD ($) property | Dec. 31, 2023 USD ($) property | Dec. 31, 2022 USD ($) | |
Debt Instrument [Line Items] | ||||
Repayments of notes payable | $ | $ 13,802 | $ 102,351 | ||
Protective Life Insurance Company | ||||
Debt Instrument [Line Items] | ||||
Number of properties covered under loan | property | 7 | |||
Number of properties, no principal and interest payments | property | 4 | |||
Number of properties under loan default | property | 3 | 3 | ||
Debt default amount | $ | $ 55,800 | $ 55,800 | ||
Protective Life Insurance Company | Subsequent Event | ||||
Debt Instrument [Line Items] | ||||
Number of properties covered under loan | property | 7 | |||
Principal balance repurchased | $ | $ 74,400 | |||
Repayments of notes payable | $ | $ 40,200 | |||
Ally Bank | Subsequent Event | ||||
Debt Instrument [Line Items] | ||||
Number of properties covered under loan | property | 6 | |||
Increase of debt | $ | $ 24,800 |
Notes Payable - Notes Payable -
Notes Payable - Notes Payable - Insurance - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Debt Instrument [Line Items] | ||
Total notes payable, net of deferred loan costs | $ 629,422 | $ 671,031 |
Notes payable - insurance | ||
Debt Instrument [Line Items] | ||
Total notes payable, net of deferred loan costs | $ 1,800 | |
Weighted average interest rate | 6.38% | |
Finance agreement term | 10 months | |
Notes payable - insurance | Minimum | ||
Debt Instrument [Line Items] | ||
Finance agreement interest rate | 6.25% | |
Notes payable - insurance | Maximum | ||
Debt Instrument [Line Items] | ||
Finance agreement interest rate | 6.50% | |
Insurance Notes Payable, Issued 2023 | Notes payable - insurance | ||
Debt Instrument [Line Items] | ||
Note principal amount | $ 3,300 | |
Insurance Notes Payable, Issued 2022 | Notes payable - insurance | ||
Debt Instrument [Line Items] | ||
Note principal amount | $ 3,100 |
Notes Payable - Other Debt Rela
Notes Payable - Other Debt Related Transactions - Narrative (Details) $ in Millions | Dec. 31, 2023 USD ($) |
Healthpeak | |
Debt Instrument [Line Items] | |
Deferred rent payments | $ 1.6 |
Notes Payable - Deferred Loan C
Notes Payable - Deferred Loan Costs - Narrative (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Disclosure [Abstract] | ||
Deferred financing cost | $ 11.6 | $ 11.3 |
Accumulated amortization | $ 7.3 | $ 6 |
Notes Payable - Debt Covenant C
Notes Payable - Debt Covenant Compliance - Narrative (Details) | Dec. 31, 2023 property |
Protective Life Insurance Company | |
Debt Instrument [Line Items] | |
Number of properties under loan default | 3 |
Securities Financing - Narrativ
Securities Financing - Narrative (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 12 Months Ended | ||||||
Nov. 01, 2023 USD ($) shares | Jun. 29, 2023 USD ($) shares | Nov. 03, 2021 USD ($) $ / shares shares | Nov. 30, 2023 USD ($) | Jul. 31, 2023 USD ($) seniorHousingCommunity shares | Dec. 31, 2023 USD ($) member designee boardSeat $ / shares | Dec. 31, 2022 USD ($) $ / shares | Nov. 30, 2021 $ / shares | |
Equity [Line Items] | ||||||||
Preferred stock, par value (in USD per share) | $ / shares | $ 0.01 | $ 0.01 | ||||||
Common stock, par value (in USD per share) | $ / shares | 0.01 | $ 0.01 | ||||||
Liquidation preference per share (in USD per share) | $ / shares | $ 1,000 | |||||||
Annual dividend rate | 11% | |||||||
Dividends | $ | $ 2,200 | |||||||
Undeclared dividends on Series A Preferred Stock | $ | $ 5,000 | $ 2,300 | ||||||
Liquidation preference percentage | 1 | |||||||
Percentage of total voting stock threshold | 50% | |||||||
Fannie Mae Loan | Forbearance Agreements | ||||||||
Equity [Line Items] | ||||||||
Principal payments | $ | $ 5,000 | |||||||
Number of payments | seniorHousingCommunity | 2 | |||||||
Mortgage Debt | ||||||||
Equity [Line Items] | ||||||||
Purchase commitment value | $ | $ 13,500 | |||||||
Sale of stock, term of offering | 18 months | |||||||
Mortgage Debt | Refinance Facility | ||||||||
Equity [Line Items] | ||||||||
Sale of stock, commitment fee payable | $ | $ 675 | |||||||
Silk | ||||||||
Equity [Line Items] | ||||||||
Number of entitled designations to the board of directors | designee | 2 | |||||||
Sonida Senior Living, Inc. | Minimum | Silk | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 5% | |||||||
Scenario One | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Number of entitled designations to the board of directors | member | 4 | |||||||
Scenario One | Sonida Senior Living, Inc. | Minimum | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 33% | |||||||
Scenario Two | Sonida Senior Living, Inc. | Minimum | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 15% | |||||||
Scenario Two | Sonida Senior Living, Inc. | Maximum | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 33% | |||||||
Scenario Three | Sonida Senior Living, Inc. | Minimum | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 20% | |||||||
Scenario Four | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Number of entitled designations to the board of directors | designee | 1 | |||||||
Scenario Four | Sonida Senior Living, Inc. | Minimum | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 5% | |||||||
Scenario Four | Sonida Senior Living, Inc. | Maximum | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 15% | |||||||
Scenario Five | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Number of entitled designations to the board of directors | boardSeat | 5 | |||||||
Period before entitlement of additional number of designations to the board of directors | 3 years 6 months | |||||||
Scenario Five | Sonida Senior Living, Inc. | Minimum | Conversant Investors | ||||||||
Equity [Line Items] | ||||||||
Ownership percentage | 50% | |||||||
Convertible Preferred Stock | ||||||||
Equity [Line Items] | ||||||||
Undeclared dividends on Series A Preferred Stock | $ | $ 5,000 | |||||||
Conversion threshold, percentage | 1.50 | |||||||
Conversion threshold, consecutive trading days | 30 days | |||||||
Convertible Preferred Stock | Private Placement | ||||||||
Equity [Line Items] | ||||||||
Proceeds from sale of stock | $ | $ 41,250 | |||||||
Common Stock | Mortgage Debt | Refinance Facility | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 67,500 | |||||||
Common Stock | Private Placement | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 400,000 | 600,000 | ||||||
Stock issued during period, value, other | $ | $ 4,000 | $ 4,000 | $ 6,000 | |||||
Common Stock | Private Placement - Existing Stockholders | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 1,133,941 | |||||||
Conversant Investors | Note Warrant | ||||||||
Equity [Line Items] | ||||||||
Warrant exercise expiration period | 5 years | |||||||
Conversant Investors | Convertible Preferred Stock | Private Placement | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 41,250 | |||||||
Preferred stock, par value (in USD per share) | $ / shares | $ 0.01 | |||||||
Price per share of stock sold (in USD per share) | $ / shares | $ 1,000 | |||||||
Conversant Investors | Common Stock | Private Placement | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 1,650,000 | |||||||
Price per share of stock sold (in USD per share) | $ / shares | $ 25 | |||||||
Common stock, par value (in USD per share) | $ / shares | 0.01 | |||||||
Conversant Investors | Common Stock | Note Warrant | ||||||||
Equity [Line Items] | ||||||||
Price per share of stock sold (in USD per share) | $ / shares | $ 40 | |||||||
Number of securities called by each warrant (in shares) | 1 | |||||||
Conversant Investors | Common Stock | Private Placement - Existing Stockholders | ||||||||
Equity [Line Items] | ||||||||
Price per share of stock sold (in USD per share) | $ / shares | $ 30 | |||||||
Conversant Investors | Common Stock | Private Placement - Backstop | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 1,160,806 | |||||||
Conversant Investors | Common Stock | Private Placement - Backstop Fee | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 174,675 | |||||||
Conversant Investors | Warrants | Note Warrant | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 1,031,250 | |||||||
Arbiter | Common Stock | Private Placement - Backstop | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 114,911 | |||||||
Arbiter | Common Stock | Private Placement - Backstop Fee | ||||||||
Equity [Line Items] | ||||||||
Shares issued under agreement (in shares) | 17,292 |
Securities Financing - Schedule
Securities Financing - Schedule of Changes To Convertible Preferred Stock (Details) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Series A Preferred Stock | ||
Balance at beginning of period (in shares) | 41 | |
Balance at beginning of period | $ 43,550 | |
Undeclared dividends on Series A Preferred Stock (in shares) | 0 | 0 |
Undeclared dividends on Series A convertible preferred stock | $ 4,992 | $ 2,300 |
Balance at end of period (in shares) | 41 | 41 |
Balance at end of period | $ 48,542 | $ 43,550 |
Stock-Based Compensation - Narr
Stock-Based Compensation - Narrative (Detail) | 12 Months Ended | |||
Jun. 15, 2023 shares | Dec. 31, 2023 USD ($) tranche $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of additional shares granted under the plan (in shares) | shares | 500,000 | |||
Options granted (in shares) | shares | 0 | 0 | ||
Stock options outstanding (in shares) | shares | 9,816 | 9,816 | ||
Stock options outstanding, intrinsic value | $ 0 | $ 0 | ||
Stock options outstanding, weighted-average remaining contractual life | 5 years | 5 years | ||
Stock options outstanding, weighted average exercise price (in USD per share) | $ / shares | $ 111.90 | $ 111.90 | ||
Unrecognized compensation expense | $ 0 | |||
Stock-based compensation expense | 2,700,000 | $ 4,300,000 | ||
Unrecognized stock based compensation expense | 3,200,000 | |||
Stock options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock-based compensation expense | $ 0 | $ 0 | ||
Restricted stock units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 1 year | |||
Time Based Restricted Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Unrecognized compensation expense, recognition period | 3 years | |||
Market Based Restricted Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 5 years | |||
Unrecognized compensation expense, recognition period | 5 years | |||
Minimum | Stock options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 1 year | |||
Minimum | Time Based Restricted Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Minimum | Performance Based Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 1 year | |||
Minimum | Market Based Restricted Stock Awards | Conversant Investors | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of tranches for shares issued | tranche | 3 | |||
Maximum | Stock options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 5 years | |||
Maximum | Time Based Restricted Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 5 years | |||
Maximum | Performance Based Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Maximum | Market Based Restricted Stock Awards | Conversant Investors | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of tranches for shares issued | tranche | 4 |
Stock-Based Compensation - Rest
Stock-Based Compensation - Restricted Stock Awards Activity (Detail) - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Restricted stock units | ||
Number of Shares | ||
Non-vested shares at beginning of period (in shares) | 8,739 | 12,816 |
Granted (in shares) | 3,000 | 8,739 |
Vested (in shares) | (8,739) | (12,816) |
Non-vested shares at end of period (in shares) | 3,000 | 8,739 |
Weighted Average Grant-Date Fair Value | ||
Non-vested shares at beginning of period (in USD per share) | $ 26.50 | $ 102.20 |
Granted (in USD per share) | 8.80 | 26.50 |
Vested (in USD per share) | 26.50 | 102.20 |
Non-vested shares at end of period (in USD per share) | $ 8.80 | $ 26.50 |
Time Based Restricted Stock Awards | ||
Number of Shares | ||
Non-vested shares at beginning of period (in shares) | 81,128 | 112,319 |
Granted (in shares) | 56,400 | 70,101 |
Forfeited/cancelled (in shares) | (2,913) | (79,327) |
Vested (in shares) | (26,044) | (21,965) |
Non-vested shares at end of period (in shares) | 108,571 | 81,128 |
Weighted Average Grant-Date Fair Value | ||
Non-vested shares at beginning of period (in USD per share) | $ 30.75 | $ 39.51 |
Granted (in USD per share) | 7.50 | 28.14 |
Forfeited/cancelled (in USD per share) | 26.50 | 34.99 |
Vested (in USD per share) | 28.72 | 51.97 |
Non-vested shares at end of period (in USD per share) | $ 19.26 | $ 30.75 |
Performance Based Stock Awards | ||
Number of Shares | ||
Non-vested shares at beginning of period (in shares) | 52,619 | 0 |
Granted (in shares) | 96,600 | 87,674 |
Forfeited/cancelled (in shares) | (35,055) | |
Non-vested shares at end of period (in shares) | 149,219 | 52,619 |
Weighted Average Grant-Date Fair Value | ||
Non-vested shares at beginning of period (in USD per share) | $ 26.40 | $ 0 |
Granted (in USD per share) | 7.03 | 28.47 |
Forfeited/cancelled (in USD per share) | 31.58 | |
Non-vested shares at end of period (in USD per share) | $ 13.86 | $ 26.40 |
Market Based Restricted Stock Awards | ||
Number of Shares | ||
Non-vested shares at beginning of period (in shares) | 171,350 | 188,411 |
Granted (in shares) | 293,600 | 60,039 |
Converted (in shares) | (77,100) | |
Non-vested shares at end of period (in shares) | 464,950 | 171,350 |
Weighted Average Grant-Date Fair Value | ||
Non-vested shares at beginning of period (in USD per share) | $ 26.97 | $ 28.20 |
Granted (in USD per share) | 8.12 | 23.19 |
Converted (in USD per share) | 27.02 | |
Non-vested shares at end of period (in USD per share) | $ 15.07 | $ 26.97 |
Income Taxes - Schedule of (Ben
Income Taxes - Schedule of (Benefit) Provision for Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Current: | ||
Federal | $ 0 | $ 0 |
State | 253 | 86 |
Deferred: | ||
Federal | 0 | 0 |
Provision for income taxes | $ 253 | $ 86 |
Income Taxes - Schedule of Prov
Income Taxes - Schedule of Provision (Benefit) for Income Taxes by Statutory Income Tax Rate (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | ||
Tax (benefit) provision at federal statutory rates | $ (4,374) | $ (11,407) |
State income tax (benefit) provision, net of federal effects | 520 | (716) |
Change in deferred tax asset valuation allowance | 1,566 | 11,253 |
Stock based compensation expense | 335 | 457 |
Permanent impact of employee retention credit claims | 2,302 | 0 |
Other | (96) | 499 |
Provision for income taxes | $ 253 | $ 86 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Taxes [Line Items] | |||
Permanent tax differences, Section 162(m) compensation limitation | $ 300 | $ 500 | |
Valuation allowance recorded | 100,838 | 99,273 | |
Valuation allowance increase | 1,600 | 11,300 | |
Permanent tax differences, deferred payroll tax penalty | 300 | ||
Deferred tax assets related to federal and state net operating loss carry forwards | 81,800 | 13,600 | |
Unrecognized tax benefits | 3,193 | 2,796 | $ 2,383 |
Federal NOL, reduction | 11,300 | ||
Domestic Tax Authority And State And Local Jurisdiction | |||
Income Taxes [Line Items] | |||
Net operating loss carry forwards | $ 389,500 | $ 305,200 |
Income Taxes - Summary of Defer
Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred tax assets: | ||
Lease liabilities | $ 377 | $ 413 |
Net operating loss carryforward | 92,251 | 84,899 |
Compensation costs | 3,233 | 2,491 |
Depreciation and amortization | 1,884 | 9 |
Other | 3,119 | 11,526 |
Total deferred tax assets | 100,864 | 99,338 |
Deferred tax asset valuation allowance | (100,838) | (99,273) |
Total deferred tax assets, net | 26 | 65 |
Deferred tax liabilities: | ||
Operating lease right-of-use assets | (26) | (65) |
Total deferred tax liabilities | (26) | (65) |
Deferred taxes, net | $ 0 | $ 0 |
Income Taxes - Schedule of Unre
Income Taxes - Schedule of Unrecognized Tax Benefits Activity and Related Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ||
Unrecognized tax benefit, at beginning of period | $ 2,796 | $ 2,383 |
Gross increases – tax positions in prior period | 397 | 413 |
Unrecognized tax benefit, at end of period | $ 3,193 | $ 2,796 |
Commitments and Contingencies (
Commitments and Contingencies (Detail) $ in Millions | Dec. 31, 2023 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Contractual obligation | $ 3.3 |
Related Party Transactions (Det
Related Party Transactions (Details) $ in Thousands | 1 Months Ended | |||||
Feb. 01, 2024 USD ($) shares | Nov. 01, 2023 USD ($) shares | Jun. 29, 2023 USD ($) shares | Nov. 30, 2023 USD ($) | Jul. 31, 2023 USD ($) shares | Dec. 31, 2023 | |
Common Stock | Subsequent Event | Conversant Investors | ||||||
Related Party Transaction [Line Items] | ||||||
Shares issued under agreement (in shares) | shares | 2,100,000 | |||||
Proceeds from sale of stock | $ | $ 20,000 | |||||
Common Stock | Private Placement | ||||||
Related Party Transaction [Line Items] | ||||||
Shares issued under agreement (in shares) | shares | 400,000 | 600,000 | ||||
Stock issued during period, value, other | $ | $ 4,000 | $ 4,000 | $ 6,000 | |||
Common Stock | Private Placement | Subsequent Event | ||||||
Related Party Transaction [Line Items] | ||||||
Shares issued under agreement (in shares) | shares | 5,026,318 | |||||
Mortgage Debt | ||||||
Related Party Transaction [Line Items] | ||||||
Purchase commitment value | $ | $ 13,500 | |||||
Mortgage Debt | Refinance Facility | ||||||
Related Party Transaction [Line Items] | ||||||
Sale of stock, commitment fee payable | $ | $ 675 | |||||
Mortgage Debt | Common Stock | Refinance Facility | ||||||
Related Party Transaction [Line Items] | ||||||
Shares issued under agreement (in shares) | shares | 67,500 | |||||
Related Party | ||||||
Related Party Transaction [Line Items] | ||||||
Ownership percentage controlling owners | 0.63 |
Fair Value - Carrying Amounts a
Fair Value - Carrying Amounts and Fair Values of Financial Instruments (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Restricted cash | $ 13,668 | $ 13,829 |
Total notes payable, net of deferred loan costs | 629,422 | 671,031 |
Carrying Amount | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and cash equivalents | 4,082 | 16,913 |
Restricted cash | 13,668 | 13,829 |
Total notes payable, net of deferred loan costs | 633,783 | 676,298 |
Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash and cash equivalents | 4,082 | 16,913 |
Restricted cash | 13,668 | 13,829 |
Total notes payable, net of deferred loan costs | $ 597,266 | $ 638,485 |
Fair Value - Narrative (Details
Fair Value - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 01, 2023 | Jul. 31, 2023 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Long-lived asset impairment | $ 5,965 | $ 1,588 | ||
Fair Value, Recurring | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fair Value | 2,100 | |||
Fair Value, Nonrecurring | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fair value of impaired property and equipment | 7,300 | 900 | ||
Interest Rate Cap | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notional amount | 138,385 | 138,385 | $ 88,100 | $ 88,100 |
Fair Value | $ 2,103 | $ 2,722 |
Derivatives and Hedging - Narra
Derivatives and Hedging - Narrative (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | |||||
Dec. 01, 2023 | Nov. 30, 2022 | Jul. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Mar. 01, 2022 | |
Interest rate caps | |||||||
Payment for derivative instruments | $ 2,362 | $ 2,703 | |||||
Interest Rate Cap | |||||||
Interest rate caps | |||||||
Notional amount | $ 88,100 | $ 88,100 | 138,385 | 138,385 | |||
Debt instrument variable rate at period end | 4% | ||||||
Payment for derivative instruments | $ 2,400 | $ 2,300 | |||||
Interest Rate Cap | Interest rate cap (LIBOR-based) | |||||||
Interest rate caps | |||||||
Notional amount | 50,260 | $ 50,300 | |||||
Interest rate cap agreement term | 24 months | ||||||
Debt instrument variable rate at period end | 4% | ||||||
Interest Rate Cap | Interest rate cap (SOFR-based) | |||||||
Interest rate caps | |||||||
Notional amount | $ 88,100 | $ 138,385 | $ 88,125 | ||||
Interest rate cap agreement term | 12 months | 12 months | |||||
Debt instrument variable rate at period end | 2.25% | 2.25% | 2.25% | ||||
Payment for derivative instruments | $ 2,400 |
Derivatives and Hedging - Sched
Derivatives and Hedging - Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Details) - Interest Rate Cap - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 01, 2023 | Jul. 31, 2023 | Dec. 31, 2022 | Nov. 30, 2022 | Mar. 01, 2022 |
Interest rate caps | ||||||
Notional amount | $ 138,385 | $ 88,100 | $ 88,100 | $ 138,385 | ||
Fair Value | 2,103 | 2,722 | ||||
Interest rate cap (LIBOR-based) | ||||||
Interest rate caps | ||||||
Notional amount | 50,260 | $ 50,300 | ||||
Fair Value | 542 | |||||
Interest rate cap (SOFR-based) | ||||||
Interest rate caps | ||||||
Notional amount | 138,385 | 88,125 | $ 88,100 | |||
Fair Value | $ 2,103 | $ 2,180 |
Derivatives and Hedging - Sch_2
Derivatives and Hedging - Schedule of Derivative Instruments (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Interest Rate Cap | Interest Expense | ||
Interest rate caps | ||
Gain (loss) on derivatives not designated as hedges included in interest expense | $ (2,981) | $ 19 |
Allowance for Doubtful Accoun_3
Allowance for Doubtful Accounts (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Balance at beginning of year | $ 5,915 | $ 4,723 |
Provision for bad debts, net of recoveries | 1,151 | 1,159 |
Write-offs and other | (1,810) | 33 |
Balance at end of year | $ 5,256 | $ 5,915 |
Subsequent Events (Details)
Subsequent Events (Details) | 1 Months Ended | 12 Months Ended | |||||||
Mar. 22, 2024 USD ($) shares | Feb. 02, 2024 USD ($) property | Feb. 01, 2024 USD ($) $ / shares shares | Dec. 31, 2023 USD ($) property $ / shares | Nov. 01, 2023 shares | Jul. 31, 2023 shares | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares | Jan. 31, 2024 USD ($) | |
Subsequent Event [Line Items] | |||||||||
Common stock, par value (in USD per share) | $ / shares | $ 0.01 | $ 0.01 | $ 0.01 | ||||||
Repayments of notes payable | $ 13,802,000 | $ 102,351,000 | |||||||
Debt transaction costs paid | 825,000 | $ 2,361,000 | |||||||
Protective Life Insurance Company | |||||||||
Subsequent Event [Line Items] | |||||||||
Number of properties covered under loan | property | 7 | ||||||||
Repurchase amount, cash funding | $ 1,500,000 | $ 1,500,000 | |||||||
Subsequent Event | Protective Life Insurance Company | |||||||||
Subsequent Event [Line Items] | |||||||||
Number of properties covered under loan | property | 7 | ||||||||
Principal balance repurchased | $ 74,400,000 | ||||||||
Repayments of notes payable | 40,200,000 | ||||||||
Repurchase amount, cash funding | $ 1,500,000 | ||||||||
Repurchase amount, equity funding | $ 15,400,000 | ||||||||
Subsequent Event | Ally Bank | |||||||||
Subsequent Event [Line Items] | |||||||||
Number of properties covered under loan | property | 6 | ||||||||
Increase of debt | $ 24,800,000 | ||||||||
Subsequent Event | Ally Bank | Interest Rate Cap | |||||||||
Subsequent Event [Line Items] | |||||||||
Debt transaction costs paid | $ 600,000 | ||||||||
Subsequent Event | Forecast | |||||||||
Subsequent Event [Line Items] | |||||||||
Stock repurchase program, additional authorized amount | $ 15,000,000 | ||||||||
Common Stock | Private Placement | |||||||||
Subsequent Event [Line Items] | |||||||||
Shares issued under agreement (in shares) | shares | 400,000 | 600,000 | |||||||
Common Stock | Subsequent Event | Private Placement | |||||||||
Subsequent Event [Line Items] | |||||||||
Shares issued under agreement (in shares) | shares | 5,026,318 | ||||||||
Common stock, par value (in USD per share) | $ / shares | $ 0.01 | ||||||||
Price per share of stock sold (in USD per share) | $ / shares | $ 9.50 | ||||||||
Common Stock | Subsequent Event | Private Placement, Equity Offering One | |||||||||
Subsequent Event [Line Items] | |||||||||
Shares issued under agreement (in shares) | shares | 3,350,878 | ||||||||
Proceeds from sale of stock | $ 31,800,000 | ||||||||
Common Stock | Subsequent Event | Private Placement, Equity Offering One | Forecast | |||||||||
Subsequent Event [Line Items] | |||||||||
Shares issued under agreement (in shares) | shares | 1,675,440 | ||||||||
Proceeds from sale of stock | $ 15,900,000 |